Facilitator

Informed consent, decisional capacity, autonomy, and withdrawal rights

Teaches how to obtain and maintain valid informed consent through clear disclosure, comprehension checks, capacity support, voluntariness, non-coercion, and respect for refusal or withdrawal. The competency also covers consent for screening procedures, recordings, collateral contact, rescue interventions, and documentation of the consent process.

8 care stages · 59 guidelines · 0 courses · 0 providers

Confidentiality, privacy, and research data protection

Teaches protection of participant identity, sensitive clinical or occupational information, recordings, and research data. The competency covers coded identifiers, restricted access, secure handling, confidentiality safeguards, and privacy-preserving documentation.

6 care stages · 53 guidelines · 0 courses · 0 providers

Screening, eligibility, and readiness assessment

Teaches how to assess clinical suitability before psychedelic or ketamine treatment, including medical and psychiatric screening, readiness evaluation, contraindication review, inclusion/exclusion criteria, and ongoing eligibility re-checks before dosing.

8 care stages · 52 guidelines · 15 courses · 12 providers

Acute psychological response and emergency management during dosing

Cluster covering 35 related competencies for monitoring acute psychological effects, recognising and managing distress, crisis containment, emergency escalation, and rescue-medication coordination during psychedelic dosing sessions.

8 care stages · 51 guidelines · 2 courses · 2 providers

Adverse event identification, documentation, and reporting

Teaches how to detect, elicit, document, and report adverse events and serious adverse events across the participant journey. The focus is accurate source documentation, regulatory reporting discipline, follow-up, and preservation of participant safety and trial integrity.

7 care stages · 46 guidelines · 0 courses · 0 providers

Preparation and integration support

Cluster covering 31 related competencies including: Integration support, Integration therapy, Integration coaching.

8 care stages · 43 guidelines · 18 courses · 14 providers

Suicide and serious psychiatric risk assessment

Teaches structured assessment of suicidal ideation, intent, psychiatric deterioration, and related high-risk presentations. Learners are trained to use appropriate tools, safety planning, emergency contacts, clinician access, and escalation pathways when risk is identified.

7 care stages · 41 guidelines · 1 courses · 1 providers

Manual fidelity, protocol adherence, and deviation management

Teaches faithful delivery of manualized treatment and protocol-defined procedures while documenting and managing unavoidable deviations. The competency protects participant welfare, treatment consistency, data integrity, and sponsor oversight.

7 care stages · 39 guidelines · 0 courses · 0 providers

Post-dose follow-up, safety monitoring, and retention support

Teaches ongoing participant contact after dosing to support stability, detect delayed adverse effects, maintain therapeutic containment, and sustain adherence to follow-up visits and outcome assessments.

7 care stages · 37 guidelines · 0 courses · 0 providers

Discharge readiness, escort safety, and post-session supervision

Teaches how to determine when a participant is safe to leave after dosing and how to arrange appropriate supervision afterward. The competency covers psychological and physical stability, escort/support-person coordination, discharge restrictions, overnight or post-session support, and follow-up contact when needed.

8 care stages · 30 guidelines · 0 courses · 0 providers

Emergency recognition, escalation, and disposition planning

Teaches recognition of medical or psychiatric emergencies and the steps required to escalate care safely. The competency includes de-escalation, clinical consultation, 911 or emergency department transfer, serious-event escalation, and referral to appropriate higher-level care.

7 care stages · 29 guidelines · 3 courses · 3 providers

Blinding, allocation concealment, and unblinding control

Teaches how to preserve blinded trial conduct across participant interactions, outcome collection, staff roles, and session procedures. The competency includes preventing accidental unblinding, minimizing bias, and using emergency unblinding only when clinically necessary.

8 care stages · 29 guidelines · 0 courses · 0 providers

Medication, substance-use, washout, and taper management

Teaches review and management of concomitant medications, restricted therapies, prohibited substances, washout periods, tapering requirements, and abstinence expectations. The competency includes participant counseling, medication reconciliation, sponsor notification, and team coordination when restrictions affect safety or interpretability.

7 care stages · 29 guidelines · 0 courses · 0 providers

Study documentation, data integrity, and regulatory recordkeeping

Teaches accurate study documentation, source-record quality, secure data capture, Good Clinical Practice recordkeeping, IRB and sponsor documentation requirements, monitoring readiness, audit support, accountability, and retention obligations.

8 care stages · 27 guidelines · 0 courses · 0 providers

Manualized psychedelic psychotherapy delivery

Teaches delivery of psychedelic-assisted psychotherapy according to an approved study manual across preparation, dosing, integration, and follow-up. The competency balances standardized structure with non-directive support for the participant’s therapeutic process.

8 care stages · 25 guidelines · 3 courses · 2 providers

Therapeutic boundaries, professional conduct, and consent for touch

Teaches how to maintain clear relational and physical boundaries in emotionally vulnerable treatment settings. This includes professional conduct, rapport without overreach, explicit consent for touch, the right to revoke consent, and strict prohibition of sexual or erotic contact.

8 care stages · 24 guidelines · 4 courses · 3 providers

Co-therapist and multidisciplinary team coordination

Teaches coordinated practice across co-therapists, physicians, psychiatrists, study coordinators, principal investigators, and other care-team members. The focus is shared responsibility, clear communication, role clarity, and coordinated observation of participant status.

8 care stages · 24 guidelines · 0 courses · 0 providers

Study record and trial registration literacy

Teaches how to understand ClinicalTrials.gov records and related study information, including glossary terms, registration fields, protocol descriptors, and results-reporting elements used to interpret clinical research records.

5 care stages · 24 guidelines · 0 courses · 0 providers

Physical safety monitoring

Cluster covering 3 related competencies including: Physical safety monitoring, Safety monitoring during dosing sessions, Medical safety monitoring during psilocybin administration.

6 care stages · 19 guidelines · 0 courses · 0 providers

Acute psychiatric and behavioral risk monitoring

Teaches continuous monitoring for distress, confusion, psychotic symptoms, suicidality, agitation, and other acute behavioral risks during and after dosing. The focus is early recognition, documentation, and escalation to clinical support when risk emerges.

7 care stages · 17 guidelines · 0 courses · 0 providers

Preparation support

Cluster covering 11 related competencies including: Preparation support, Psilocybin preparation, Therapeutic preparation.

8 care stages · 16 guidelines · 6 courses · 5 providers

Ethical conduct in human-subject research

Able to practice ethically in a clinical trial environment involving a Schedule-sensitive psychoactive intervention. This includes protecting participants, adhering to protocol, and supporting valid informed participation.

7 care stages · 16 guidelines · 0 courses · 0 providers

Supportive nondirective therapeutic stance

Cluster covering 6 related competencies including: Therapeutic support during dosing, Nondirective dosing-session presence, Supportive dosing-session facilitation.

7 care stages · 16 guidelines · 0 courses · 0 providers

Therapeutic alliance building

Cluster covering 2 related competencies including: Therapeutic alliance building, Therapeutic alliance and rapport building.

7 care stages · 15 guidelines · 1 courses · 1 providers

Good Clinical Practice and protocol procedure compliance

Teaches adherence to Good Clinical Practice, assigned study roles, protocol procedures, delegation boundaries, and applicable research regulations. The competency supports consistent execution of approved procedures across sites and participants.

5 care stages · 15 guidelines · 0 courses · 0 providers

Psilocybin session facilitation

Cluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.

8 care stages · 14 guidelines · 6 courses · 5 providers

Adverse effects and side-effect management

Teaches recognition and management of expected and unexpected side effects during psychedelic or ketamine treatment. The competency emphasizes active observation, supportive response, and clinical escalation when symptoms exceed routine tolerability.

6 care stages · 14 guidelines · 1 courses · 1 providers

Psychedelic-assisted psychotherapy preparation and integration

Teaches structured pre-dose preparation and post-dose integration as the therapeutic frame for psychedelic-assisted psychotherapy. The therapist supports rapport, intention clarification, meaning-making, emotional processing, and consolidation of insights after dosing.

8 care stages · 13 guidelines · 2 courses · 2 providers

Hallucinogen pharmacology and effects

Cluster covering 7 related competencies including: Physiologic safety awareness, Hallucinogen pharmacology and effects, Hallucinogen-assisted therapy knowledge.

6 care stages · 13 guidelines · 0 courses · 0 providers

Ketamine psychotherapy delivery

Cluster covering 12 related competencies including: KAP psychotherapy delivery, Ketamine and KAP knowledge, Ketamine integration planning.

8 care stages · 12 guidelines · 7 courses · 5 providers

Dissociation and acute neuropsychiatric effect monitoring

Teaches recognition and documentation of dissociation, psychosis-like symptoms, mania, and other acute neuropsychiatric effects that can occur after ketamine, psychedelic dosing, or related interventions. The focus is monitoring, reporting, and escalation when symptoms become clinically significant.

7 care stages · 12 guidelines · 0 courses · 0 providers

Physiologic monitoring, thermoregulation, hydration, and overdose response

Teaches monitoring and response for acute physiological risks, including vital signs, temperature, hydration, overheating, excessive fluid intake, and suspected overdose. The competency emphasizes supportive care, medical coordination, documentation, and escalation when needed.

5 care stages · 11 guidelines · 0 courses · 0 providers

Special-interest adverse event vigilance

The protocol requires active monitoring for psychedelic-specific adverse events such as hallucinations, psychotic symptoms, dissociation, mood alteration, and cognitive disturbance. These require immediate notification and follow-up.

7 care stages · 11 guidelines · 0 courses · 0 providers

Depression symptom and remission monitoring

Teaches structured monitoring of depressive symptoms, response, and remission across treatment and follow-up. Learners use standardized scales and clinical review to track change and identify deterioration or non-response.

6 care stages · 10 guidelines · 0 courses · 0 providers

Mindfulness, intention-setting, set and setting, and somatic presence

Teaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.

7 care stages · 9 guidelines · 7 courses · 6 providers

Trauma-informed therapeutic presence and somatic support

Teaches a trauma-informed stance during psychedelic work, including calm presence, non-verbal reassurance, body-aware support, somatic orientation, and containment through difficult experiences while maintaining safety and boundaries.

6 care stages · 9 guidelines · 2 courses · 2 providers

Comprehensive psychiatric assessment

Ability to perform or supervise detailed psychiatric evaluation for diagnosis, eligibility, and ongoing monitoring. The therapist/facilitator must understand symptom presentations relevant to MDD, AUD, suicidality, psychosis, and dissociation.

4 care stages · 9 guidelines · 0 courses · 0 providers

Ensure confidentiality and session containment

Maintain a contained therapeutic environment that protects the patient’s privacy and minimizes unwanted exposure. The session structure emphasizes confidentiality and controlled access to stimulation and outside contact.

6 care stages · 9 guidelines · 0 courses · 0 providers

Grounding and regulation techniques

Therapists must be able to teach and coach grounding practices that help participants regulate during preparation and dosing. These methods are used before medication and during distress.

6 care stages · 9 guidelines · 0 courses · 0 providers

Outcome Measure and Assessment Literacy

Teaches clinicians and research staff to understand the purpose, limits, scoring, interpretation, and clinical meaning of psychological measures and study instruments used to evaluate symptoms, functioning, safety, and treatment outcomes.

7 care stages · 9 guidelines · 0 courses · 0 providers

Client preparation and therapeutic set/setting

Cluster covering 2 related competencies including: Preparation of set and setting, Client preparation and therapeutic set/setting.

6 care stages · 8 guidelines · 2 courses · 2 providers

Continuation, discontinuation, and risk-benefit judgment

Teaches how clinicians determine whether a participant should proceed, pause, discontinue dosing, or terminate study participation. The competency centers on safety-driven clinical judgment, risk-benefit assessment, and early termination when continuation is no longer appropriate.

6 care stages · 8 guidelines · 0 courses · 0 providers

Participant safety restriction counseling

Teaches how to instruct participants on post-dose and study-period restrictions that reduce risk from impaired judgment, unsafe activity, prohibited substances, or behaviors that could confound study outcomes.

6 care stages · 8 guidelines · 0 courses · 0 providers

Physiologic monitoring during ketamine administration

Cluster covering 2 related competencies including: Safety monitoring during ketamine dosing, Physiologic monitoring during ketamine administration.

6 care stages · 8 guidelines · 0 courses · 0 providers

Psychedelic-assisted therapy facilitation

Cluster covering 2 related competencies including: Psychedelic-assisted therapy facilitation, Group facilitation in a psychedelic setting.

6 care stages · 8 guidelines · 0 courses · 0 providers

Psychological support during altered states

Provides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.

7 care stages · 8 guidelines · 0 courses · 0 providers

Training and competency maintenance

Therapists and study personnel are expected to receive structured training and ongoing supervision. Competence includes both protocol adherence and the ability to work safely and consistently across sites.

6 care stages · 8 guidelines · 0 courses · 0 providers

Use outcome assessment and follow-up to evaluate response

The study used standardized anxiety measures and followed patients for 2 months and 12 months, implying competence in tracking outcomes over time. Therapists should be able to assess symptom change and sustained benefit using structured follow-up.

5 care stages · 8 guidelines · 0 courses · 0 providers

Vital sign and physical distress monitoring

Monitors participant physical status during study visits and identifies concerning changes requiring escalation. Vital signs and symptomatic changes are part of routine safety observation.

6 care stages · 8 guidelines · 0 courses · 0 providers

Cultural humility, Indigenous respect, and equity-oriented care

Teaches culturally responsive psychedelic care, including humility, anti-bias practice, Indigenous and traditional-use awareness, cultural appropriation concerns, diversity and inclusion, and respectful work with marginalized communities.

8 care stages · 7 guidelines · 11 courses · 10 providers

Transference, countertransference, and therapist self-awareness

Teaches recognition and management of relational dynamics that can intensify in psychedelic-assisted therapy. Learners develop self-awareness around countertransference, projection, attachment, dependency, and other therapeutic-process risks.

6 care stages · 7 guidelines · 1 courses · 1 providers

Clinical interviewing and history-taking

Therapists and study clinicians perform detailed biopsychosocial interviewing during preparation and screening. This supports treatment planning, risk assessment, and therapeutic understanding.

5 care stages · 7 guidelines · 0 courses · 0 providers

Clinical Interviewing and PTSD Assessment

Teaches structured clinical interviewing and assessment administration for PTSD and related symptom domains, including symptom severity, functional impairment, risk factors, and appropriate use of standardized assessment tools.

7 care stages · 7 guidelines · 0 courses · 0 providers

Dose escalation decision support

The therapist/facilitator must support structured dose escalation decisions within the individualized dosing regimen. Decisions depend on both patient-reported peak experience and clinical tolerability/safety judgments.

2 care stages · 7 guidelines · 0 courses · 0 providers

Participant-centered discharge planning and aftercare

Support decision-making about ongoing treatment after trial completion, particularly for participants who received escitalopram. The clinician helps participants consider whether to continue, taper, or return to usual care.

5 care stages · 7 guidelines · 0 courses · 0 providers

Safe Therapeutic Container Creation

Teaches providers to create and maintain a psychologically and physically safe therapeutic setting through clear structure, preparation, boundaries, attunement, environmental design, and ongoing attention to participant safety.

5 care stages · 6 guidelines · 2 courses · 2 providers

Cultural and spiritual sensitivity

Responds respectfully to spiritual, mystical, and value-related themes that may arise during psilocybin sessions and debriefing. Integrates these themes into therapy without imposing interpretations.

3 care stages · 6 guidelines · 0 courses · 0 providers

Integration and post-session debriefing

Cluster covering 4 related competencies including: Integration and debriefing, Integration and debriefing facilitation, Integration and post-session debriefing.

6 care stages · 6 guidelines · 0 courses · 0 providers

Ketamine infusion monitoring

Cluster covering 5 related competencies including: Cardiac safety monitoring, Ketamine infusion monitoring, Ketamine infusion administration.

6 care stages · 6 guidelines · 0 courses · 0 providers

Medical screening and medication review

Therapists/investigators must understand the medical suitability requirements for LSD-assisted psychotherapy and coordinate medication washout and concomitant medication review. This includes recognizing drug-drug interaction risks and contraindications.

3 care stages · 6 guidelines · 0 courses · 0 providers

Medication taper and withdrawal monitoring

Teaches monitoring during down-titration or discontinuation of psychiatric medications before dosing. Learners track withdrawal symptoms, symptom worsening, suicidality, and other risks that may emerge during tapering.

4 care stages · 6 guidelines · 0 courses · 0 providers

Professional boundaries and recording consent

Therapists may record sessions only with explicit participant consent and must handle recordings for training and research within protocol limits. Recording is part of the therapeutic and scientific framework, not routine clinical use.

5 care stages · 6 guidelines · 0 courses · 0 providers

Reproductive risk, contraception, and pregnancy monitoring

Teaches counseling and monitoring around contraception, reproductive restrictions, pregnancy risk, and pregnancy-related discontinuation rules. Learners are trained to explain requirements clearly and respond promptly when pregnancy or reproductive-safety concerns arise.

5 care stages · 6 guidelines · 0 courses · 0 providers

Safe treatment-setting facilitation

Provide a calm and supportive environment during treatment to reduce distress and support tolerance of the experience. The case report notes food, rest, and a quiet place as part of care.

6 care stages · 6 guidelines · 0 courses · 0 providers

Therapeutic rapport building

Cluster covering 4 related competencies including: Therapeutic rapport building, Rapport building and trust development, Therapeutic rapport and trust building.

5 care stages · 6 guidelines · 0 courses · 0 providers

Psilocybin psychotherapy framework

Cluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.

8 care stages · 5 guidelines · 4 courses · 2 providers

Ethical psychedelic facilitation

Cluster covering 3 related competencies including: Ethical psychedelic facilitation, Safe, legal psychedelic care facilitation, Ethical decision-making in psychedelic facilitation.

8 care stages · 5 guidelines · 2 courses · 2 providers

Session facilitation and therapeutic holding

Cluster covering 2 related competencies including: Session facilitation and therapeutic holding, Session facilitation and support during intense experiences.

5 care stages · 5 guidelines · 2 courses · 2 providers

Management of concomitant medication interactions

Cluster covering 5 related competencies including: Concomitant medication review, Contraindication and interaction awareness, Contraindications, drug effects, and interactions.

5 care stages · 5 guidelines · 1 courses · 1 providers

Assessment administration and interpretation

Ability to administer and interpret structured interviews, clinician ratings, and self-report measures used in the study. Therapists contribute to eligibility, safety, and outcome assessment.

7 care stages · 5 guidelines · 0 courses · 0 providers

Evaluate clinically significant response and treatment outcomes

Therapists/facilitators should be able to judge whether therapeutic change reaches clinically meaningful thresholds, not just whether symptoms improve numerically. This supports informed ongoing care and communication about benefits and limitations.

6 care stages · 5 guidelines · 0 courses · 0 providers

Facilitate processing of difficult emotions

Therapists must help patients face and work through grief, fear, rage, panic, shame, guilt, and existential distress rather than avoid them. The clinician supports emotional expression while maintaining safety and meaning-making.

4 care stages · 5 guidelines · 0 courses · 0 providers

Knowledge of PTSD and fear extinction theory

Understand the clinical and neurobehavioral rationale for PE and exposure-based treatment. The therapist should know how extinction learning is conceptualized in the study model.

4 care stages · 5 guidelines · 0 courses · 0 providers

Match dose and setting to patient capacity

Therapists/facilitators need judgment about dosing and setting so experiences remain tolerable and therapeutically useful. The paper repeatedly notes that when dose and setting are appropriate, emerging material remains within the patient’s capacity to cope.

3 care stages · 5 guidelines · 0 courses · 0 providers

Participant education and informed consent communication

Clinicians and research staff must clearly educate participants about study procedures, risks, side effects, restrictions, and possible benefits, and obtain written informed consent before screening and study participation. Ethical delivery depends on transparent communication and opportunities for questions.

6 care stages · 5 guidelines · 0 courses · 0 providers

Participant safety planning and support network coordination

Can identify and involve support persons, attendants, and outside providers to enhance safety. The facilitator must coordinate practical supports while respecting confidentiality and protocol boundaries.

6 care stages · 5 guidelines · 0 courses · 0 providers

Provide overnight and next-day containment

Therapists must ensure continuity of care after the acute session, including overnight observation and next-morning integration before discharge. This reflects a containment and recovery responsibility beyond the dosing period.

5 care stages · 5 guidelines · 0 courses · 0 providers

Research assessment administration

Administer study measures and structured assessments on schedule, including psychological, spiritual, and neurobehavioral instruments. This includes both paper-based and Storyline-based assessments.

5 care stages · 5 guidelines · 0 courses · 0 providers

Respect autonomy and individualized communication preferences

Adapt language and interpersonal style to the patient’s preferences to promote dignity and comfort. The therapist should also respect the patient’s autonomy within safety limits.

4 care stages · 5 guidelines · 0 courses · 0 providers

Risk screening and exclusion judgment

Know the medical and psychiatric exclusions that protect participants from foreseeable harm. Facilitators must recognize conditions that make MDMA-assisted psychotherapy unsafe or inappropriate.

4 care stages · 5 guidelines · 0 courses · 0 providers

Trauma-focused exposure facilitation

Facilitate trauma exposure in a structured, supportive, and protocol-consistent manner. The therapist must be able to initiate, pace, and process exposure work while maintaining adherence to PE methods.

5 care stages · 5 guidelines · 0 courses · 0 providers

Understand dose-response and time course

The facilitator should know how oral and intravenous dosing relate to onset, duration, and peak effects. This knowledge supports proper session planning, monitoring, and integration timing.

6 care stages · 5 guidelines · 0 courses · 0 providers

Professional self-care and burnout prevention

Teaches sustainable self-care practices for clinicians and facilitators working in emotionally intense settings. The competency supports emotional resilience, ethical boundaries, reflective practice, and burnout prevention.

6 care stages · 4 guidelines · 3 courses · 3 providers

Risk evaluation and safety monitoring

Teaches continuous evaluation of clinical risk and maintenance of a safe care environment throughout preparation, dosing, and follow-up. Learners monitor risk signals, apply safety procedures, and escalate care when needed.

8 care stages · 4 guidelines · 3 courses · 2 providers

Music and therapist-variable awareness

The course explicitly mentions the role of music and therapist variables in treatment. Learners are expected to understand how these elements influence the PAP experience and therapeutic outcome.

5 care stages · 4 guidelines · 1 courses · 1 providers

Therapeutic touch judgment

The training includes appropriate use of therapeutic touch as part of safe delivery. Learners are expected to use touch judiciously and within ethical boundaries.

5 care stages · 4 guidelines · 1 courses · 1 providers

Working with inner healing intelligence

The course teaches how to work with the 'Inner Healing Intelligence,' indicating a non-directive or facilitative stance toward client-led healing processes. This is framed as a core therapeutic concept in psychedelic work.

4 care stages · 4 guidelines · 1 courses · 1 providers

Addiction and OUD treatment knowledge

Facilitator must understand opioid use disorder, medication-assisted treatment, and the clinical rationale for adjunctive psychotherapy. The protocol frames MORE+KAP as an investigational augmentation to buprenorphine treatment.

4 care stages · 4 guidelines · 0 courses · 0 providers

Controlled-substance handling awareness

Understands that MDMA is a Schedule 1 investigational product and must be stored, dispensed, and accounted for under regulatory control. Supports compliant handling during the session.

4 care stages · 4 guidelines · 0 courses · 0 providers

Dosage judgment and administration safety

Competent facilitation requires practical knowledge of dosage ranges, initial dosing, boosters, formulation handling, and administration errors. The handbook stresses both clinical judgment and meticulous procedural care.

3 care stages · 4 guidelines · 0 courses · 0 providers

Facilitate integration of experience into behavioral change

Cluster covering 2 related competencies including: Integration of psychedelic experience with behavior change, Facilitate integration of experience into behavioral change.

4 care stages · 4 guidelines · 0 courses · 0 providers

Independent outcome assessment administration

The facilitator must administer and coordinate patient-rated and clinician-rated measures while minimizing bias. Assessments should be completed independently and in the correct order.

4 care stages · 4 guidelines · 0 courses · 0 providers

Manage agitation and elopement risk

Respond to agitation or attempts to leave the room in a way that preserves safety for the patient and others. The therapist should use containment, redirection, and escalation protocols when needed.

4 care stages · 4 guidelines · 0 courses · 0 providers

Management of residual symptoms and re-entry

Therapists must prepare the subject for residual effects after the main session and provide practical safeguards for sleep, transportation, and home support. This includes framing recurrence of symptoms in a non-alarming way.

3 care stages · 4 guidelines · 0 courses · 0 providers

MDMA administration oversight

Study clinicians are responsible for administering study drug, ensuring correct dose assignment, and supervising safe oral ingestion during blinded sessions. This includes verifying visit-specific randomization information and ensuring dosing is delivered under the blinded workflow.

3 care stages · 4 guidelines · 0 courses · 0 providers

Monitor acute and short-term adverse effects

The study emphasizes the absence of acute or chronic adverse effects persisting beyond 1 day and no treatment-related serious adverse events, indicating the need for active monitoring during and after treatment. Facilitators must be able to observe, document, and respond to adverse reactions.

5 care stages · 4 guidelines · 0 courses · 0 providers

Narrative elicitation and phenomenological listening

Therapists must be able to elicit a full account of the dosing experience without overinterpreting it. The goal is to help participants remember, narrate, and reflect on their experience in detail.

3 care stages · 4 guidelines · 0 courses · 0 providers

Nonintrusive session monitoring and containment

Facilitators must balance active safety monitoring with minimal interference in the participant’s inner experience. The role includes maintaining continuous presence, periodic check-ins, and preserving the therapeutic container of the session.

4 care stages · 4 guidelines · 0 courses · 0 providers

Pre-session dosing behavior instructions

Teaches clear communication of behavioral requirements before dosing sessions so conditions are standardized and preventable risks are reduced. Staff confirm that participants understand and follow pre-session instructions.

4 care stages · 4 guidelines · 0 courses · 0 providers

Prioritize participant wellbeing over research aims

Participant safety and wellbeing must take precedence over scientific objectives at all times. Therapists must communicate and operationalize this priority throughout screening, treatment, and follow-up.

4 care stages · 4 guidelines · 0 courses · 0 providers

Psilocybin psychoeducation

Cluster covering 2 related competencies including: Psilocybin psychoeducation, Psychedelic psychoeducation and expectation management.

6 care stages · 4 guidelines · 0 courses · 0 providers

Recognition of contraindications and risk states

Therapists/facilitators must know the psychiatric and medical conditions that make KPT unsafe or inappropriate. Safe practice depends on excluding high-risk individuals.

3 care stages · 4 guidelines · 0 courses · 0 providers

Recognize limits of evidence and avoid overstatement

Therapists and facilitators should communicate treatment effects responsibly and acknowledge methodological limitations. The paper notes small sample size, lack of long-term control group, and need for further study of mechanisms.

3 care stages · 4 guidelines · 0 courses · 0 providers

Respect for cultural and indigenous context

The use of ayahuasca requires sensitivity to its traditional indigenous and ceremonial origins. Facilitators should avoid reducing the practice to a purely technical intervention and should respect cultural meaning and ceremonial context.

4 care stages · 4 guidelines · 0 courses · 0 providers

Structured symptom rating administration

Facilitators must competently administer and interpret clinician-rated ADHD and global severity measures. Accurate scoring is essential because these scales determine eligibility and outcomes.

4 care stages · 4 guidelines · 0 courses · 0 providers

Substance use assessment

Ability to evaluate alcohol and other substance use patterns using standardized tools and clinical interview. This is essential for eligibility, safety, and outcome monitoring.

4 care stages · 4 guidelines · 0 courses · 0 providers

Crisis and adverse-event response

The page signals training in managing difficult or high-risk moments, including crisis intervention and trigger management. Learners are expected to respond appropriately when a session becomes destabilizing or unsafe.

6 care stages · 3 guidelines · 1 courses · 1 providers

Safety monitoring and emergency awareness

The page points to checklists and a guide to basic medical emergencies, indicating that learners should be able to monitor safety and recognize urgent issues. The overall training context also stresses keeping both client and practitioner safe.

6 care stages · 3 guidelines · 1 courses · 1 providers

Assess outcomes and psychological change

The framework implies competence in evaluating both symptom change and subjective outcomes over time. The study used standardized anxiety measures and qualitative interviews to assess sustained effects and patient-reported change.

4 care stages · 3 guidelines · 0 courses · 0 providers

Attendant supervision and role clarity

Therapists must ensure attendants are appropriately selected and instructed for overnight monitoring. Attendants provide supportive care and observation without taking on psychotherapeutic functions.

3 care stages · 3 guidelines · 0 courses · 0 providers

Balance inner focus with communication

Therapists should support an appropriate rhythm between inward experiential focus and verbal interaction, with either therapist or participant able to initiate shifts.

3 care stages · 3 guidelines · 0 courses · 0 providers

Behavioral monitoring and outcome assessment

Collect smoking-related behavioral data and participant-reported outcomes repeatedly across the trial. Facilitators must accurately gather self-report, breath CO, urine, and questionnaire data according to protocol.

3 care stages · 3 guidelines · 0 courses · 0 providers

Blinded Assessment and Independent Rating

Teaches the use of independent or blinded assessors to reduce expectancy and observer bias, preserve separation between therapeutic and rating roles, manage unblinding risks, and protect outcome validity in open-label or partially blinded designs.

3 care stages · 3 guidelines · 0 courses · 0 providers

Cardiac risk monitoring

Monitor for ibogaine-associated cardiac toxicity, especially QTc prolongation and risk of torsades de pointes. This includes baseline exclusion screening, frequent ECG surveillance, and escalation when QTc becomes markedly prolonged.

3 care stages · 3 guidelines · 0 courses · 0 providers

Elicit and formulate positive intentions

Help the patient identify personally meaningful, positive intentions to guide the session and future change. Intentions should be active, concrete, and framed toward desired gains rather than avoidance.

2 care stages · 3 guidelines · 0 courses · 0 providers

Empathic presence and listening

Therapists must listen with nonjudgmental, emotionally attuned presence and convey validation, reassurance, and curiosity. They should be able to stay relaxed yet engaged, including noticing nonverbal cues and responding without prying.

3 care stages · 3 guidelines · 0 courses · 0 providers

Expectation and expectancy management

Understand how treatment expectations can influence treatment response and study interpretation. Facilitation must avoid inadvertently shaping expectations in a biased or misleading way.

3 care stages · 3 guidelines · 0 courses · 0 providers

Facilitating insight and peak experiences

The protocol assumes therapeutic value in insight, catharsis, and peak experiences, so the therapist must support conditions that may allow these to emerge safely and meaningfully. This includes recognizing and working with symbolic and transformative material.

2 care stages · 3 guidelines · 0 courses · 0 providers

Handle altered, irrational, or hallucinatory narratives without invalidation

Accept the patient’s experience as meaningful without disputing or forcing interpretation. The therapist supports reflection while avoiding premature conclusions about reality or correctness.

3 care stages · 3 guidelines · 0 courses · 0 providers

Informed consent and treatment briefing

Therapists/facilitators must support ethically valid informed consent by ensuring participants understand the intervention, expectations, risks, and logistics. They also provide anticipatory guidance before ketamine sessions and discharge information after dosing.

3 care stages · 3 guidelines · 0 courses · 0 providers

Informed consent responsibility

Facilitators are responsible for ensuring that participants have provided informed consent before receiving MDMA-assisted therapy. This reflects an ethical and regulatory duty central to work with investigational treatments.

4 care stages · 3 guidelines · 0 courses · 0 providers

Informed preparation and orientation of the subject

The therapist is responsible for giving truthful, individualized preparation and reassurance about the experience, including likely sensations, risks of resistance, and expectations for conduct. The preparation aims to reduce fear, improve cooperation, and support voluntary participation.

4 care stages · 3 guidelines · 0 courses · 0 providers

Interdisciplinary coordination across mental health and medical services

Combined ketamine infusion and PE treatment requires coordination between psychotherapy providers and medical/anesthesia or medication administration staff. Effective collaboration supports timing, safety oversight, and protocol fidelity.

5 care stages · 3 guidelines · 0 courses · 0 providers

Knowledge of ayahuasca pharmacology and effects

Understand the basic pharmacology and clinical effects of ayahuasca to inform safe facilitation and interpretation of responses. The source identifies dimethyltryptamine as a 5-HT2A agonist and harmine as a monoamine-oxidase A inhibitor.

4 care stages · 3 guidelines · 0 courses · 0 providers

Knowledge of MDMA effects and risks

Facilitators must understand the expected psychological, physiological, and potential adverse effects of MDMA in order to prepare participants, support the session, and detect complications.

5 care stages · 3 guidelines · 0 courses · 0 providers

Laboratory and ECG safety review

Reviews laboratory and ECG data for clinically relevant abnormalities and determines whether continued participation is appropriate. Escalates abnormalities requiring repeat testing or specialist input.

2 care stages · 3 guidelines · 0 courses · 0 providers

Maintain scientific and ethical caution in representing benefits

Because the paper notes limited conclusions about efficacy due to the crossover design, clinicians have an ethical responsibility to avoid overstating treatment effects. Competence includes accurately presenting the evidence base, uncertainty, and limits of inference to patients and colleagues.

2 care stages · 3 guidelines · 0 courses · 0 providers

Mindfulness instruction

Facilitator can teach and cue mindfulness practices consistent with the study protocol. Mindfulness is presented as present-moment, nonjudgmental awareness.

5 care stages · 3 guidelines · 0 courses · 0 providers

MRI safety screening and imaging-session coordination

Teaches screening for MRI contraindications and coordination of imaging clearance before scan procedures. The competency prevents exposure of ineligible participants to magnetic-resonance risks and supports safe imaging-session logistics.

3 care stages · 3 guidelines · 0 courses · 0 providers

No extractable therapist/facilitator competencies in provided source text

The provided source text is only a ClinicalTrials.gov interface/header snippet and does not contain study intervention procedures, therapist qualifications, facilitator responsibilities, safety monitoring procedures, or ethical guidance specific to clinical practice.

2 care stages · 3 guidelines · 0 courses · 0 providers

Opioid withdrawal assessment

Evaluates opioid withdrawal symptoms and tracks changes over time in participants discontinuing methadone OST. Uses standardized withdrawal ratings to assess potential treatment effects and safety.

4 care stages · 3 guidelines · 0 courses · 0 providers

Practice nondirective, participant-led facilitation

A core competency is following rather than steering the participant’s process, intervening only in service of the unfolding inner-directed experience.

2 care stages · 3 guidelines · 0 courses · 0 providers

Pre-treatment clinical risk assessment

Understand the major medical risks associated with ibogaine administration, especially cardiac and neurologic toxicity, before proceeding with treatment. This includes recognizing that ibogaine has been linked to torsades de pointes, QTc prolongation, bradycardia, and ataxia.

4 care stages · 3 guidelines · 0 courses · 0 providers

Professional qualifications and experience threshold

The manual specifies baseline professional requirements for study therapists. These include licensure and substantial clinical experience with psychiatric populations.

3 care stages · 3 guidelines · 0 courses · 0 providers

Psychoeducation about MDMA effects and session trajectory

Therapists must understand MDMA’s expected subjective, interpersonal, and physiological effects and prepare participants accordingly. This knowledge supports normalization, reassurance, and effective use of the medicine within therapy.

4 care stages · 3 guidelines · 0 courses · 0 providers

Psychological preparation and anxiety reduction

Facilitators need practical skills in preparing participants emotionally for ketamine administration and reducing distress. The protocol highlights relaxation, breathing, and grounding strategies to reduce anxiety or discomfort associated with the drug experience.

3 care stages · 3 guidelines · 0 courses · 0 providers

Psychological state assessment

Administer and interpret psychological and psychometric measures relevant to mood, cravings, expectations, mystical experience, ego dissolution, and functioning. Facilitators must accurately support questionnaire-based assessment across time points.

5 care stages · 3 guidelines · 0 courses · 0 providers

Research rating fidelity

Ability to administer standardized clinical ratings consistently and under supervision. Reliable measurement is essential for efficacy and safety endpoints.

4 care stages · 3 guidelines · 0 courses · 0 providers

Safety monitoring of vital signs and cardiovascular effects

Monitor and respond to the expected sympathomimetic effects of MDMA. The therapist/facilitator must be alert to transient increases in blood pressure, pulse, and related cardiac symptoms.

3 care stages · 3 guidelines · 0 courses · 0 providers

Setting optimization

Create an environment that supports safety, comfort, and relaxation during the session. The setting is deliberately structured to reduce anxiety and facilitate a positive experience.

5 care stages · 3 guidelines · 0 courses · 0 providers

Special population sensitivity in advanced cancer

Tailor therapeutic engagement to patients with advanced non-operable GI cancers facing existential distress, grief, and limited life expectancy. The therapist/facilitator must recognize the emotional and medical context of end-of-life suffering.

2 care stages · 3 guidelines · 0 courses · 0 providers

Substance use relapse monitoring

Ability to monitor for opioid use recurrence, other substance use, and ketamine misuse during the trial. The clinician must recognize relapse risk and take action when substance use worsens.

3 care stages · 3 guidelines · 0 courses · 0 providers

Support peak or mystical-type experiences without imposing them

Facilitators should be able to contain and make therapeutic use of profound emotional or peak experiences, including ego loosening, awe, reassurance, and feelings of unity or peace. The article suggests these experiences can be highly meaningful and therapeutic, but not all need to meet full mystical criteria.

3 care stages · 3 guidelines · 0 courses · 0 providers

Support safe administration of LSD dosing sessions

Because the protocol involved specific LSD doses, active placebo control, and session spacing, facilitators need applied skill in implementing dosing-session procedures safely and consistently. This includes maintaining therapeutic support while adhering to protocol constraints.

4 care stages · 3 guidelines · 0 courses · 0 providers

Support structured symptom monitoring

Although formal measurements may be conducted by another researcher, therapists/facilitators must work within a protocol that includes repeated anxiety assessments and daily diaries of anxiety, pain, and medication use. This implies competence in reinforcing adherence to monitoring procedures and integrating findings into care awareness.

3 care stages · 3 guidelines · 0 courses · 0 providers

Teach and apply stress inoculation and anxiety support

Therapists should identify or teach in-session coping tools and collaboratively plan how anxiety states will be recognized and supported.

3 care stages · 3 guidelines · 0 courses · 0 providers

Therapeutic rapport and engagement support

Help patients engage in emotionally intense trauma-focused treatment and reduce dropout risk. The therapist should recognize comorbid depression or anxiety that may interfere with adherence and response.

5 care stages · 3 guidelines · 0 courses · 0 providers

Training and certification in study instruments

Teaches the requirement for site personnel to be trained and certified on protocol-specific assessments, psychiatric instruments, rating scales, and study procedures before performing them in the trial.

4 care stages · 3 guidelines · 0 courses · 0 providers

Trauma treatment background

Therapists need a solid professional background in psychotherapy, especially PTSD treatment. Prior experience with established trauma therapies and related approaches is considered important preparation for this work.

4 care stages · 3 guidelines · 0 courses · 0 providers

TRD eligibility assessment

Understands and applies the protocol-defined criteria for treatment-resistant major depressive disorder, including diagnostic confirmation, episode severity, and prior treatment failure requirements. Must verify both current and historical antidepressant nonresponse and ensure the participant remains eligible at baseline.

3 care stages · 3 guidelines · 0 courses · 0 providers

Understanding of trial procedures and schedule

Know the sequence, timing, and purpose of screening, preparation, dosing, scanning, follow-up, and unblinding visits. The therapist/facilitator must be able to work within the full protocol structure.

6 care stages · 3 guidelines · 0 courses · 0 providers

Use clear, participant-centered communication

Therapists should communicate in language and nonverbal style the participant can readily follow, avoiding overly theoretical or confusing discourse.

3 care stages · 3 guidelines · 0 courses · 0 providers

Virtual care facilitation

Capacity to conduct assessments and therapy sessions virtually when needed while preserving safety and confidentiality. The study permits telehealth sessions for certain visits and contingencies.

4 care stages · 3 guidelines · 0 courses · 0 providers

Voluntary participation and non-coercion

The handbook explicitly states that the experience should be fully explained and that the subject should accept it voluntarily. Coercion is framed as both unethical and therapeutically counterproductive.

4 care stages · 3 guidelines · 0 courses · 0 providers

Harm reduction and risk awareness

Cluster covering 5 related competencies including: Harm-reduction orientation, Harm reduction and risk awareness, Harm reduction for client support.

8 care stages · 2 guidelines · 5 courses · 5 providers

Dosing-day facilitation

Cluster covering 2 related competencies including: Dosing-day facilitation, Dosing-session facilitation.

4 care stages · 2 guidelines · 2 courses · 2 providers

Legal and Regulatory Navigation

Teaches practitioners to identify and apply relevant legal, regulatory, ethical, and institutional requirements, including documentation, consent, reporting, controlled-substance, and jurisdiction-specific obligations.

7 care stages · 2 guidelines · 2 courses · 2 providers

Basic life support

Learners are explicitly offered Basic Life Support training, indicating emergency readiness and medical safety preparation. The page notes DORA-required status, signaling regulatory safety relevance.

4 care stages · 2 guidelines · 1 courses · 1 providers

Facilitator self-awareness and self-care

The program includes facilitator development and self-care, and it explicitly calls on learners to recognize personal limitations and seek support. This suggests training in reflective practice and professional self-management.

4 care stages · 2 guidelines · 1 courses · 1 providers

Guided inquiry and reflective language

Students learn to use language and questions that deepen a client’s inner experience and support healing. This is a practical communication competency for facilitation and integration work.

5 care stages · 2 guidelines · 1 courses · 1 providers

Therapist self-regulation

The curriculum explicitly includes therapist self-regulation as a therapeutic skill. This suggests learners are expected to maintain steadiness and presence while supporting clients in altered states.

3 care stages · 2 guidelines · 1 courses · 1 providers

Action planning and relapse-prevention support

Helps participants convert motivation into specific behavior-change strategies. Uses structured planning tools and individualized modules to address triggers, coping, and alternative behaviors.

2 care stages · 2 guidelines · 0 courses · 0 providers

Assess and engage support systems

Therapists should understand the participant’s support network and appropriately involve support persons when relevant and desired.

5 care stages · 2 guidelines · 0 courses · 0 providers

Assessment of emotional stability after sessions

Therapists must remain with participants at the end of and immediately after experimental sessions until emotional stability is established. This requires real-time clinical judgment about readiness for reduced supervision.

3 care stages · 2 guidelines · 0 courses · 0 providers

Assessment of indications and contraindications

The therapist must exercise clinical judgment about who may benefit, who may have difficulty surrendering defenses, and where evidence is limited. The handbook emphasizes uncertainty, need for research, and cautious selection based on insecurity, rigidity, suspicion, diagnosis, and treatment goals.

3 care stages · 2 guidelines · 0 courses · 0 providers

Baseline history taking

Collect and interpret baseline behavioral, psychiatric, and medical history relevant to psilocybin research. This information is used to determine eligibility and contextualize outcomes.

4 care stages · 2 guidelines · 0 courses · 0 providers

Clinical trial participant eligibility boundaries

Therapists must practice within the population and setting defined by the manual, limiting use to approved clinical trial subjects with PTSD. This boundary helps protect participants and preserves research integrity.

2 care stages · 2 guidelines · 0 courses · 0 providers

Cognitive safety monitoring

Ability to monitor for short-term cognitive impairment following psychedelic administration. The study included tests designed to detect decrements in attention and processing speed.

3 care stages · 2 guidelines · 0 courses · 0 providers

Collaboration with medical supervision

Therapists function within a medically supervised ketamine model and must coordinate closely with clinicians responsible for dosing oversight and safety clearance. This includes understanding role boundaries and supporting monitoring workflows.

2 care stages · 2 guidelines · 0 courses · 0 providers

Competence in protocol adherence for dosing sessions

The intervention involved two separate psilocybin dosing sessions 3 weeks apart under a randomized controlled protocol, implying the need for facilitators to reliably support treatment according to a fixed schedule and study procedures.

4 care stages · 2 guidelines · 0 courses · 0 providers

Conduct qualitative, client-centered inquiry

Facilitators/research therapists should be able to elicit and understand patients’ subjective experience from a client-centered perspective. The study used semi-structured interviews focused on experience, anxiety, quality of life, and values.

2 care stages · 2 guidelines · 0 courses · 0 providers

Confidential and nonjudgmental therapeutic stance

Facilitators should create a safe interpersonal environment conducive to disclosure and processing. The setting is intentionally designed to support openness, comfort, and trust.

3 care stages · 2 guidelines · 0 courses · 0 providers

Coordinate with outside providers ethically

Therapists must coordinate with prescribing clinicians and existing psychotherapists when relevant, while respecting consent and confidentiality. Communication should support safety, continuity, and protocol integrity.

3 care stages · 2 guidelines · 0 courses · 0 providers

Coordination with community recovery supports

For alcohol use problems, the handbook expects therapists to connect subjects with Alcoholics Anonymous and similar social supports, framing the psychedelic experience as an introduction rather than a cure. This is a competency in continuing care planning.

2 care stages · 2 guidelines · 0 courses · 0 providers

Cultural and language competence for participation

Staff must ensure participants can understand and engage with the protocol in the site’s recognized language and can participate in a way that preserves safety and informed consent. This is part of the practical knowledge needed for ethical facilitation.

2 care stages · 2 guidelines · 0 courses · 0 providers

Deliver mindfulness and grounding exercises

Use brief mindfulness practices and grounding strategies to stabilize attention and reduce distress before and during the session. These techniques help the patient reconnect to present-moment awareness and bodily sensation.

3 care stages · 2 guidelines · 0 courses · 0 providers

Empathic presence and active listening

Therapists are expected to provide consistent empathic presence, nonjudgmental attunement, and deep listening throughout the process. This includes validating feelings, listening for deeper meaning, and creating psychological permission for openness.

5 care stages · 2 guidelines · 0 courses · 0 providers

Ethical sourcing and ecological responsibility

The review explicitly discourages clinical development based on toad venom because of ethical and ecological concerns. Facilitators should favor synthetic sources and avoid practices that could harm wildlife or ecosystems.

2 care stages · 2 guidelines · 0 courses · 0 providers

Experience with altered states of consciousness

Facilitators are expected to have substantial prior experience supporting altered states of consciousness. This experience supports containment, trust, and skilled response to unusual perceptual and emotional phenomena.

2 care stages · 2 guidelines · 0 courses · 0 providers

Group facilitation and relationship management

When leading group sessions, therapists must manage group size, relational instability, empathic bonds, exclusion dynamics, and mutual support among therapists. The handbook treats group structure as a clinically important variable.

2 care stages · 2 guidelines · 0 courses · 0 providers

Judicious use of interpretation

Therapists may offer interpretations or insights, but these should be minimized and subordinated to the participant’s own discernment. The model values participant-led meaning making over therapist-imposed explanations.

2 care stages · 2 guidelines · 0 courses · 0 providers

Knowledge of study population and indications

Understands the clinical and occupational context of the treated population. Facilitators should be aware that the target group consisted of frontline physicians and nurses with depression and burnout related to the COVID-19 pandemic.

1 care stage · 2 guidelines · 0 courses · 0 providers

Laboratory safety monitoring

Review laboratory and biomarker data for clinically significant abnormalities, including chemistry, hematology, coagulation, and alcohol biomarkers. This supports medical safety surveillance during follow-up.

3 care stages · 2 guidelines · 0 courses · 0 providers

Maintain beginner’s mind

Therapists should cultivate openness about both the participant’s process and their own interpretations. This prevents forcing experience into rigid theoretical frames and supports curiosity and compassion.

3 care stages · 2 guidelines · 0 courses · 0 providers

Manage mandated reporting and safety concerns

Therapists/facilitators must fulfill professional legal duties and escalate safety or reporting concerns promptly.

3 care stages · 2 guidelines · 0 courses · 0 providers

Management of assessment-related distress

Because interviews and questionnaires may provoke emotional reactions or fatigue, facilitators must respond supportively and mitigate burden. This includes addressing distress during assessments and offering breaks.

4 care stages · 2 guidelines · 0 courses · 0 providers

Motivational enhancement for quitting

Elicit and strengthen motivation to quit smoking and remain abstinent. Facilitators use sessions to explore values, reasons for quitting, and treatment commitment.

3 care stages · 2 guidelines · 0 courses · 0 providers

Motivational interviewing and enhancement

Uses motivational interviewing methods to strengthen intrinsic motivation and commitment to change. Tailors discussions to the participant’s ambivalence, goals, and readiness to change drinking behavior.

4 care stages · 2 guidelines · 0 courses · 0 providers

Nasal tolerability assessment

Performs targeted nasal examinations and assesses local tolerability of esketamine nasal spray. Identifies findings that could affect drug delivery, safety, or continuation.

3 care stages · 2 guidelines · 0 courses · 0 providers

Nausea and vomiting management

Recognize and respond to gastrointestinal adverse effects that may occur frequently with higher doses. Manage emesis to reduce aspiration risk, dehydration, and treatment disruption.

3 care stages · 2 guidelines · 0 courses · 0 providers

Neutral, unbiased facilitation

The facilitator must minimize bias in how assessments are administered and in how participant responses are handled. This is important because the trial is open-label and relies heavily on patient-reported outcomes.

2 care stages · 2 guidelines · 0 courses · 0 providers

Non-directive facilitation

Therapists must facilitate rather than control the participant's process, using invitations and timing interventions carefully. They should preserve the participant-led unfolding of experience while knowing when gentle direction or safety-based assertiveness is needed.

2 care stages · 2 guidelines · 0 courses · 0 providers

Non-responder handoff and continuity of care

The facilitator must ensure non-responders are transitioned safely back to clinical care. Continuity of care is explicitly required to support ongoing psychiatric treatment.

4 care stages · 2 guidelines · 0 courses · 0 providers

Optional biomarker/genomic research handling

Understands the optional nature and operational limits of biomarker and pharmacogenomic collection. Ensures consent, timing, fasting guidance, and sample handling requirements are respected.

3 care stages · 2 guidelines · 0 courses · 0 providers

Outcome and safety measure literacy

Knowledge of the trial’s primary, secondary, and exploratory endpoints and the instruments used to assess them. This enables accurate administration and interpretation of study procedures.

4 care stages · 2 guidelines · 0 courses · 0 providers

Patient monitoring during ibogaine administration

Monitors patients closely during treatment because serious adverse outcomes may occur. Safety monitoring is essential given that one participant died during treatment in the study.

3 care stages · 2 guidelines · 0 courses · 0 providers

Peak experience assessment

Ability to assess whether the target acute psychedelic experience has occurred using the study-defined scale and threshold. This was used to guide individualized dosing.

3 care stages · 2 guidelines · 0 courses · 0 providers

Pharmacokinetic awareness

Understands the drug’s rapid absorption profile and lack of accumulation with repeated dosing. Uses this knowledge to anticipate timing of effects and safety observations.

2 care stages · 2 guidelines · 0 courses · 0 providers

Practice within evidence limitations and communicate uncertainty

Therapists should accurately represent the current evidence base and avoid overstating efficacy or durability. The article notes significant short-term benefit but also the need for larger multicenter trials and longer follow-up.

2 care stages · 2 guidelines · 0 courses · 0 providers

Professional qualification and supervised practice

Lead therapists must hold appropriate licensure and regulatory registration to provide psychotherapy, and have prior PAP experience. Unlicensed or inexperienced therapists may participate only under direct supervision.

2 care stages · 2 guidelines · 0 courses · 0 providers

Protocol adherence and visit scheduling

Ability to manage the study schedule, windows, and follow-up procedures accurately. This supports treatment delivery and valid outcome collection.

4 care stages · 2 guidelines · 0 courses · 0 providers

Psychedelic phenomenology literacy

Understand the characteristic acute experiential domains elicited by ayahuasca. This includes perceptual, somatic, cognitive, affective, mystical, and temporal-spatial alterations.

3 care stages · 2 guidelines · 0 courses · 0 providers

Respiratory monitoring

Facilitators must watch for slowed breathing, sleep apnea-related hypoxia, disordered breathing, and oxygen desaturation. Oxygenation needs ongoing assessment during the acute and post-acute periods.

4 care stages · 2 guidelines · 0 courses · 0 providers

Risk-benefit judgment

Balances potential symptom relief against known and emerging safety risks in participants with opioid dependence. Makes conservative decisions when cardiac or adverse-effect concerns outweigh anticipated benefit.

2 care stages · 2 guidelines · 0 courses · 0 providers

Safety monitoring for adverse effects

Monitors for potential adverse effects associated with ibogaine administration and the detoxification period, even though the abstract primarily reports outcomes rather than specific events.

3 care stages · 2 guidelines · 0 courses · 0 providers

Safety oversight and independent review

Clinical investigators must work within independent safety monitoring structures and avoid conflicts in oversight roles. Therapists/facilitators in research settings should support scheduled review of participant safety outcomes.

2 care stages · 2 guidelines · 0 courses · 0 providers

Session pacing and timing

Therapists must pace the day appropriately, from early dosing to flexible termination, avoiding premature ending that could destabilize the subject. The handbook presents timing as an active facilitative skill rather than a logistical detail.

2 care stages · 2 guidelines · 0 courses · 0 providers

Shared decision-making and referral coordination

Collaborates with patients, medical practitioners, and referring providers to support individualized care. Helps patients consider alternatives and coordinate ongoing treatment needs.

4 care stages · 2 guidelines · 0 courses · 0 providers

Source verification and documentation awareness

Maintains accuracy and transparency when using registry sources for competency extraction. The facilitator should avoid overclaiming details that are not present in the available record text.

1 care stage · 2 guidelines · 0 courses · 0 providers

Stress inoculation and breathwork instruction

At least one therapist must be able to teach stress inoculation methods, especially diaphragmatic breathing, and apply breath-based interventions during sessions. Breath is used both for relaxation and for staying present with difficult experience.

4 care stages · 2 guidelines · 0 courses · 0 providers

Support patients with moderate-to-severe major depressive disorder

Therapists/facilitators require knowledge of treating patients with moderate-to-severe major depressive disorder in the context of psychedelic-assisted therapy. The target population in the trial establishes disorder-specific clinical knowledge needs.

1 care stage · 2 guidelines · 0 courses · 0 providers

Track cognitive performance during treatment

Because cognitive performance during treatment is a named secondary outcome, clinicians involved in care should be able to monitor and document cognitive functioning relevant to treatment participation. This supports safety oversight and interpretation of treatment effects.

3 care stages · 2 guidelines · 0 courses · 0 providers

Training in PAP and protocol manual adherence

Therapists must be specifically trained in psilocybin-assisted psychotherapy and in the study’s manualized procedures. Competence includes familiarity with the therapeutic model and difficult-state management guidance.

4 care stages · 2 guidelines · 0 courses · 0 providers

Treatment-condition matching and support

Deliver comparable behavioral support across psilocybin and NRT conditions while respecting protocol differences. Facilitators must maintain treatment fidelity and avoid bias toward one arm.

2 care stages · 2 guidelines · 0 courses · 0 providers

Understanding MDMA effects and non-linear healing

Therapists must have a thorough understanding of MDMA’s subjective, relational, and physiological effects, including the non-linear way these may support healing. This knowledge is necessary for preparation, in-session decisions, and normalization of participant experiences.

4 care stages · 2 guidelines · 0 courses · 0 providers

Use of structured clinical and psychological measures

Therapists/facilitators should know the main assessment domains used in KPT research and clinical monitoring, including craving, depression, anxiety, anhedonia, addiction severity, and purpose in life. This knowledge supports case formulation and tracking change.

2 care stages · 2 guidelines · 0 courses · 0 providers

Use of structured rating scales

The therapist/facilitator or designated rater must administer and interpret multiple structured clinical scales reliably. Training and separation of roles are required to preserve rating quality and blinding.

3 care stages · 2 guidelines · 0 courses · 0 providers

Values clarification and committed action coaching

Therapists must help participants identify, recover, and translate values into concrete behavior change. The manual treats values work as central to depression recovery and integration.

4 care stages · 2 guidelines · 0 courses · 0 providers

Video review and supervision participation

Work within a supervised treatment model that includes review of recorded sessions and feedback. The facilitator must accept supervision, use feedback constructively, and support fidelity reviews.

2 care stages · 2 guidelines · 0 courses · 0 providers

Withdrawal symptom assessment

Measure opioid withdrawal severity using standardized instruments and interpret symptom severity over time. Facilitators must be able to collect both objective observation and patient-reported data.

4 care stages · 2 guidelines · 0 courses · 0 providers

Work with bodily sensations and somatic process

Therapists should orient to and explore the participant’s somatic experience, both in experimental and integrative sessions, as a central channel of processing.

3 care stages · 2 guidelines · 0 courses · 0 providers

Work with psychodynamic material

Therapists need knowledge of psychodynamic processes likely to arise under LSD, including emergence of previously excluded material, abreaction, catharsis, and memory-rich reliving of past experiences. The discussion explicitly identifies these as mechanisms relevant to treatment.

2 care stages · 2 guidelines · 0 courses · 0 providers

Work within medically supervised settings

LSD-assisted psychotherapy in this study is explicitly framed as medically supervised. Therapists/facilitators need to practice within a setting capable of medical oversight and management of prolonged altered states.

2 care stages · 2 guidelines · 0 courses · 0 providers

Working with family/collateral supports

The protocol expects involvement of relatives in follow-up, indicating a facilitator competency in engaging collateral supports. This helps verify outcomes and sustain recovery monitoring.

4 care stages · 2 guidelines · 0 courses · 0 providers

Psychedelic research literacy and evidence appraisal

Teaches how to interpret the psychedelic clinical evidence base, compare strength of evidence across indications, understand mechanism theories, and critically appraise research claims. The competency supports evidence-informed practice rather than relying on general field narratives.

7 care stages · 1 guidelines · 11 courses · 8 providers

Integration support and meaning-making

Cluster covering 2 related competencies including: Integration support and meaning-making, Meaning-making and integration support.

3 care stages · 1 guidelines · 4 courses · 4 providers

Trauma-informed care

Cluster covering 2 related competencies including: Trauma-informed care, Trauma-informed psychedelic care.

8 care stages · 1 guidelines · 4 courses · 4 providers

Professional Scope and Practice Alignment

Teaches clinicians to recognise their role boundaries, align services with training, licensure, supervision, and organisational policy, and refer or escalate when participant needs fall outside their scope of competence.

5 care stages · 1 guidelines · 3 courses · 2 providers

Pharmacology, contraindications, and interaction awareness

Teaches psychoactive substance pharmacology, expected drug effects, contraindications, and relevant drug-interaction risks. The competency supports safer screening, medication review, participant education, and clinical decision-making.

4 care stages · 1 guidelines · 2 courses · 2 providers

Psychedelic integration support

Cluster covering 2 related competencies including: Psychedelic integration support, Psychedelic knowledge integration.

5 care stages · 1 guidelines · 2 courses · 2 providers

Psychotherapeutic facilitation methods

Cluster covering 2 related competencies including: Facilitation of psychedelic journeys, Psychotherapeutic facilitation methods.

6 care stages · 1 guidelines · 2 courses · 2 providers

Psychedelic harm reduction and integration fundamentals

Cluster covering 2 related competencies including: Psychedelic harm reduction and integration therapy, Psychedelic harm reduction and integration fundamentals.

5 care stages · 1 guidelines · 2 courses · 1 providers

Trauma-informed practice

Cluster covering 2 related competencies including: Trauma-informed practice, Trauma-informed clinical practice.

7 care stages · 1 guidelines · 2 courses · 1 providers

Confidentiality and trust maintenance

The course explicitly discusses confidentiality, especially in underground practice and with anonymous practitioners. Learners are expected to understand confidentiality as a core part of maintaining safe and effective psychedelic care relationships.

5 care stages · 1 guidelines · 1 courses · 1 providers

Use of adjunctive therapeutic modalities

Advanced trainings mention topics like IFS, art therapy, breathwork, and integration, implying learners can deepen their practice with complementary methods. These are presented as continuing development topics rather than core prerequisites.

3 care stages · 1 guidelines · 1 courses · 1 providers

Accurate source limitation recognition

Ability to acknowledge when the source does not contain therapist or facilitator competency information. The extractor should not overstate what can be supported by the text.

1 care stage · 1 guidelines · 0 courses · 0 providers

ACT-informed psychoeducation and skills teaching

Therapists teach ACT concepts in a way that helps participants recognize depression-related patterns and build psychological flexibility. The manual expects direct instruction plus experiential learning.

1 care stage · 1 guidelines · 0 courses · 0 providers

Active listening micro-skills

Therapists are expected to use concrete active listening skills that support exploration without overdirecting. These communication skills help maintain emotional safety and participant agency.

1 care stage · 1 guidelines · 0 courses · 0 providers

Acute monitoring of subjective intensity

Track the participant’s subjective drug intensity during the active phase of the session. This includes recognizing when the participant cannot respond and how to document maximum intensity.

3 care stages · 1 guidelines · 0 courses · 0 providers

Adaptation to diverse diagnoses

Ability to apply KAP flexibly across multiple diagnostic presentations. The article describes benefit in patients with a wide variety of diagnoses.

1 care stage · 1 guidelines · 0 courses · 0 providers

Address transference and countertransference openly

Therapists should be aware of transference and countertransference, which may be intensified in non-ordinary states. They are expected to respond with honesty, self-awareness, and openness rather than leaving important relational dynamics unspoken.

1 care stage · 1 guidelines · 0 courses · 0 providers

Administration of vaporized 5-MeO-DMT

Ability to correctly deliver the investigational inhaled drug using standardized vaporization procedures and participant instructions. Safe and accurate administration is central to the dosing protocol.

1 care stage · 1 guidelines · 0 courses · 0 providers

Alcohol abstinence screening and enforcement

Ensure required abstinence conditions are met before dosing and make clinical judgments about rescheduling or exclusion when they are not. This protects safety and protocol integrity.

4 care stages · 1 guidelines · 0 courses · 0 providers

Alcohol use disorder assessment

Understands diagnostic and clinical features of alcohol dependence and related severity measures used in the protocol. Uses this knowledge to inform eligibility, treatment focus, and outcome interpretation.

1 care stage · 1 guidelines · 0 courses · 0 providers

Alcohol use disorder clinical knowledge

Have a working understanding of moderate to severe AUD, relapse processes, craving, withdrawal, and common comorbidities. This knowledge is required to deliver the integrated treatment model safely and effectively.

3 care stages · 1 guidelines · 0 courses · 0 providers

Appropriate compensation transparency

Financial arrangements should be communicated clearly and handled transparently. Facilitators should avoid ambiguity around fees, deposits, scholarships, and contribution models.

1 care stage · 1 guidelines · 0 courses · 0 providers

Appropriate facilitator qualifications

Lead facilitators were doctoral-level psychologists or physicians with major depressive disorder treatment experience, and co-facilitators had at least a bachelor’s degree in a mental health-related field. The source therefore indicates role-appropriate clinical background and experience requirements.

2 care stages · 1 guidelines · 0 courses · 0 providers

Assess and prepare social support

Therapists should evaluate the participant’s support network and help plan how supports can assist between sessions. They must also guide participants about the benefits and risks of disclosing their experiences to others.

3 care stages · 1 guidelines · 0 courses · 0 providers

Assess and treat anxiety related to life-threatening disease

The intervention targets anxiety associated with life-threatening diseases, so therapists need knowledge of the psychological burden of severe medical illness and the clinical presentation of anxiety in this population. They must be able to formulate treatment needs in medically ill patients.

1 care stage · 1 guidelines · 0 courses · 0 providers

Assess psychosocial functioning

Competent delivery includes monitoring psychosocial functioning in addition to depressive symptoms. The source reports psychosocial functioning as a treatment outcome sustained through follow-up.

3 care stages · 1 guidelines · 0 courses · 0 providers

Assessment of existential distress and mood symptoms

Administer and interpret the study's psychosocial measures relevant to existential distress, depression, spiritual well-being, and death-related distress. These assessments are used for screening and outcome monitoring.

2 care stages · 1 guidelines · 0 courses · 0 providers

Assessment of psychological readiness and vulnerability

Before administration, facilitators should assess readiness and factors that could increase the chance of a difficult session. The source highlights that preoccupation, rigidity, low trust, and poor support can worsen experiences.

4 care stages · 1 guidelines · 0 courses · 0 providers

Assessment of treatment response

Track onset, duration, and phases of ibogaine effects as part of clinical monitoring. The manual describes multiple stages of effect and expects the provider to observe them carefully.

3 care stages · 1 guidelines · 0 courses · 0 providers

Assessment-related participant support

Therapists and study staff must manage participant distress and fatigue associated with questionnaires and interviews. Competence includes pacing, offering breaks, and responding supportively to emotionally evocative content.

2 care stages · 1 guidelines · 0 courses · 0 providers

Ataxia and neurologic monitoring

Assess for cerebellar adverse effects such as ataxia during and after ibogaine administration. The source indicates ataxia is likely driven by ibogaine exposure and should be tracked systematically.

3 care stages · 1 guidelines · 0 courses · 0 providers

Attention to participant experience and perceived coercion

Therapists and research facilitators should evaluate how participants experienced study involvement, including perceived costs, benefits, and pressure to participate. This reflects an ethical responsibility to monitor the quality and voluntariness of participation over time.

2 care stages · 1 guidelines · 0 courses · 0 providers

Authenticity and trustworthiness

Facilitators should present as authentic, relatable, and trustworthy, and be open to participant questions and feedback. Establishing a credible and safe relational basis is part of responsible practice.

2 care stages · 1 guidelines · 0 courses · 0 providers

Awareness of functional unblinding

Recognize that strong psychoactive effects can reveal treatment allocation and influence ratings. This awareness is important for interpreting subjective reports and maintaining methodological rigor.

1 care stage · 1 guidelines · 0 courses · 0 providers

Awareness of interaction and formulation cautions

The therapist/facilitator must understand potential drug-interaction concerns and formulation-related differences that could alter tolerability or safety. The source mentions caution with antiemetics and alternative preparations.

3 care stages · 1 guidelines · 0 courses · 0 providers

Behavioral assessment administration

Trained staff must administer and/or supervise a battery of behavioral tasks and self-report instruments consistently across baseline and drug sessions. Some measures are verbally administered by clinicians or coordinators and require standardized delivery.

3 care stages · 1 guidelines · 0 courses · 0 providers

Benzodiazepine withdrawal management

Providers must know that ibogaine does not treat benzodiazepine withdrawal and that sudden cessation can be dangerous. Benzodiazepine-dependent patients should not be told to stop abruptly.

1 care stage · 1 guidelines · 0 courses · 0 providers

Body position and postural support

The facilitator should understand how posture affects the experience and support safer, freer bodily expression. Positioning may include lying down, sitting, standing, or allowing spontaneous movement as appropriate.

1 care stage · 1 guidelines · 0 courses · 0 providers

Boundary management in a dual-role therapeutic model

Navigate the combination of psychedelic support and AUD therapy while preserving clear therapeutic boundaries. The facilitator must deliver supportive care without role confusion or undue influence.

3 care stages · 1 guidelines · 0 courses · 0 providers

Boundary-respecting physical support

Use physical contact only when necessary, explicitly permitted, and minimal. The facilitator must respect participant autonomy and avoid any contact that is not justified for safety or grounding.

2 care stages · 1 guidelines · 0 courses · 0 providers

Candidate selection and risk-benefit assessment

Evaluate whether a person is an appropriate candidate for ibogaine treatment by balancing potential benefit against medical risk. This includes identifying treatment-refractory opioid use disorder and weighing cardiotoxicity and other safety concerns against the harms of untreated substance use disorder.

2 care stages · 1 guidelines · 0 courses · 0 providers

Cardiac safety and QT monitoring

Understands and monitors concentration-related cardiac risk, especially QTc prolongation, in participants receiving noribogaine or similar agents. Uses ECG findings to support safe trial conduct and participant protection.

1 care stage · 1 guidelines · 0 courses · 0 providers

Cardiovascular safety screening

Screen for cardiovascular risk before treatment because ibogaine may prolong the QT interval and has been linked to arrhythmias and deaths. Exclude or carefully manage patients with cardiac disease and other risk factors.

2 care stages · 1 guidelines · 0 courses · 0 providers

Care for a selected clinical population

The conclusion emphasizes that findings apply to a selected group of patients, implying the importance of appropriate patient selection and caution in generalization when facilitating treatment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Causality assessment

Assess whether an event is related to treatment and resolve uncertainty through team discussion and regulatory escalation. The protocol uses a structured causality framework from unrelated to definitely related.

1 care stage · 1 guidelines · 0 courses · 0 providers

CBT expertise for mood disorders

Clinicians must have working expertise in evidence-based CBT for depression and related mood conditions, including the ability to deliver core CBT components across preparation, post-session integration, and relapse prevention phases. The protocol assumes competence in standard CBT delivery as the psychosocial backbone of treatment.

4 care stages · 1 guidelines · 0 courses · 0 providers

Check-in and timing of interventions during sessions

Therapists must skillfully time check-ins and interventions to sustain process without unnecessary intrusion. They monitor silence, talking, avoidance, and signs of internal engagement to decide when to inquire, redirect, or simply witness.

3 care stages · 1 guidelines · 0 courses · 0 providers

Clinical experience for assistant facilitator

Assistant facilitators require practical clinical experience in a licensed healthcare setting. Their role supports safety, containment, and session logistics rather than independent psychotherapy practice.

2 care stages · 1 guidelines · 0 courses · 0 providers

Clinical judgment for exclusion of high-risk patients

Exclude or defer patients whose medical risk is too high, especially those with cardiovascular disease or other major contraindications. This is central to safer administration according to the source.

3 care stages · 1 guidelines · 0 courses · 0 providers

Clinical judgment on treatment optimization

Uses observed patient response to help optimize how ketamine-assisted psychotherapy is administered. Informs future clinical decisions about approach and dosing strategy.

1 care stage · 1 guidelines · 0 courses · 0 providers

Cognitive-behavioral smoking cessation counseling

Deliver structured CBT-based smoking cessation support throughout the trial. Facilitators teach practical self-management strategies before and after the target quit date.

2 care stages · 1 guidelines · 0 courses · 0 providers

Collaboratively address trauma material

Therapists should obtain agreement that trauma may be gently brought up if not spontaneously addressed, while preserving participant choice and collaborative exploration.

1 care stage · 1 guidelines · 0 courses · 0 providers

Combination risk awareness

Facilitators must know that combining 5-MeO-DMT with other psychoactives or MAO-inhibitors can be dangerous or fatal. Careful pacing and separation from other substances are necessary.

2 care stages · 1 guidelines · 0 courses · 0 providers

Community network and sustainability building

Responsible practitioners cultivate relationships with other practitioners and community networks to support sustainable care. They help build systems that expand access while preserving integrity and safety.

2 care stages · 1 guidelines · 0 courses · 0 providers

Conduct structured follow-up assessments

After completion of PE, patients are assessed over a 3-month follow-up period at multiple time points, requiring clinician or facilitator competence in longitudinal follow-up procedures. This includes maintaining contact and collecting outcome information consistently.

2 care stages · 1 guidelines · 0 courses · 0 providers

Confidential and accurate data collection

Collects and records substance use, withdrawal, and follow-up data accurately and responsibly in clinical or research settings.

2 care stages · 1 guidelines · 0 courses · 0 providers

Confidential, respectful handling of subjective disclosures

Treat participant disclosures during interviews and integration as sensitive clinical information. The facilitator should elicit and document experiences respectfully and without judgment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Contextualization and ceremony design

Facilitators may use ritual, music, prayer, altar work, or minimalist approaches to frame the experience. Whatever the style, they should use contextualization intentionally and in service of the participant’s process.

3 care stages · 1 guidelines · 0 courses · 0 providers

Continuous physical monitoring

Participants must be continuously monitored to prevent avoidable hazards. The guide explicitly states that participants should never be left alone.

1 care stage · 1 guidelines · 0 courses · 0 providers

Contraindication identification

Knows the conditions that may disqualify a person from ketamine treatment and can apply that knowledge during screening. Recognizes medical, psychiatric, pregnancy-related, and substance-related contraindications.

1 care stage · 1 guidelines · 0 courses · 0 providers

Contribute to treatment acceptability assessment

Clinicians should be able to evaluate and support treatment acceptability from both participant and clinician perspectives. The pilot reported high acceptability ratings by participants and study clinicians.

1 care stage · 1 guidelines · 0 courses · 0 providers

Controlled inhalation administration

Can safely administer vaporized GH001 using standardized equipment and procedure. Accurate delivery and participant instruction are essential to reliable dosing.

2 care stages · 1 guidelines · 0 courses · 0 providers

Coordination with backup facilitators and monitor

Facilitators must work in a structured team environment with a separate study monitor and backup facilitators. They need to respond rapidly when additional 1:1 support is required and accept direction from the lead facilitator and PI.

1 care stage · 1 guidelines · 0 courses · 0 providers

COVID-19 infection control

Implement infection-prevention procedures during in-person study and dosing visits. Facilitators must screen participants, use PPE, maintain distancing when feasible, and adapt procedures based on test results or symptoms.

3 care stages · 1 guidelines · 0 courses · 0 providers

Cultivate beginner’s mind

Therapists should encourage participants to set aside rigid expectations and remain open to whatever arises during experimental sessions.

1 care stage · 1 guidelines · 0 courses · 0 providers

Cultural and ceremonial competence

Able to participate in or support ceremonial treatment elements respectfully and appropriately. The source indicates ceremonial behavior and traditional medicine are part of the intervention, requiring cultural competence and sensitivity.

1 care stage · 1 guidelines · 0 courses · 0 providers

Cultural awareness and inclusion

The training framework explicitly includes cultural awareness and inclusion, and examples identify culturally insensitive behavior as clinically inappropriate.

1 care stage · 1 guidelines · 0 courses · 0 providers

CYP2D6 genotype-informed dosing

Use pharmacogenetic information to anticipate altered ibogaine metabolism and exposure. The study identifies CYP2D6 activity as a major determinant of ibogaine clearance.

1 care stage · 1 guidelines · 0 courses · 0 providers

Data element compliance awareness

Understands the obligation to follow defined data element standards when submitting or interpreting study information. This is relevant to accurate, non-misleading representation of therapist/facilitator qualifications.

1 care stage · 1 guidelines · 0 courses · 0 providers

Delegation and escalation

Facilitators should know when and how to ask for help and delegate tasks. This is essential in emergencies and difficult situations.

1 care stage · 1 guidelines · 0 courses · 0 providers

Detect and address unethical attitudes or behaviors

Trainers and mentors observe therapists for conduct that could place participants at risk. Therapists must be receptive to correction and able to modify problematic behavior or seek additional training.

1 care stage · 1 guidelines · 0 courses · 0 providers

Device deficiency and product quality complaint handling

Identifies and reports device deficiencies and product quality complaints related to the nasal spray device or product packaging. Ensures immediate escalation when malfunctions or labeling issues occur.

1 care stage · 1 guidelines · 0 courses · 0 providers

Documentation and note-taking

Document participant experiences and relevant observations to support continuity, recall, and study integrity. Notes may also serve as a participant memory aid after dosing sessions.

4 care stages · 1 guidelines · 0 courses · 0 providers

Documentation of subjective experience

The therapist/facilitator must record participant-reported effects and clinically relevant observations accurately. Documentation supports both safety monitoring and outcome interpretation.

3 care stages · 1 guidelines · 0 courses · 0 providers

Dose-response observation

Tracks dose-dependent changes without assuming full psychedelic effects. This includes recognizing that low-dose exposure may modulate brain activity while remaining sub-psychedelic.

1 care stage · 1 guidelines · 0 courses · 0 providers

Drug interaction and mechanism awareness

Understand the role of serotonergic mechanisms and the implications of receptor antagonism for acute psychedelic effects. Use this knowledge to interpret responses and co-administration effects.

2 care stages · 1 guidelines · 0 courses · 0 providers

Dyadic facilitation and gender-balanced therapeutic presence

Experimental sessions are conducted by a male physician-investigator and an experienced female nurse, indicating competency in co-therapy, complementary roles, and continuous therapeutic presence.

1 care stage · 1 guidelines · 0 courses · 0 providers

Eating disorder clinical knowledge

Knowledge of anorexia nervosa symptomatology, risk, and clinical instability relevant to screening and treatment monitoring. The study requires awareness of eating-disorder-specific risks and outcomes.

2 care stages · 1 guidelines · 0 courses · 0 providers

Electrolyte and medical screening

Assess for physiologic factors that may increase ibogaine-related harm, especially electrolyte abnormalities. The source identifies electrolyte screening as part of safer administration.

4 care stages · 1 guidelines · 0 courses · 0 providers

Elicit expectations, fears, and concerns

Therapists should proactively explore participants’ hopes, fears, concerns, and expectations about treatment and address them responsively.

1 care stage · 1 guidelines · 0 courses · 0 providers

Eligibility documentation and accountability

Document eligibility decisions, registrations, and protocol compliance accurately and completely. This includes signed checklists, source documentation, and investigator attestation.

1 care stage · 1 guidelines · 0 courses · 0 providers

Emergency medication knowledge

Knows the purpose and indications of medications maintained for side effect management or emergency use during KAP. Can explain how these medications relate to specific risks.

1 care stage · 1 guidelines · 0 courses · 0 providers

Emergency planning

A clear emergency plan is required before the session begins. The whole team must understand what to do in various scenarios.

1 care stage · 1 guidelines · 0 courses · 0 providers

Empathic sensitivity and nonverbal attunement

The handbook expects therapists to perceive and respond to the subject’s feeling state with heightened empathy, especially when verbal communication is reduced. This is particularly emphasized in individual sessions and in group work where nonverbal emotional communication becomes prominent.

1 care stage · 1 guidelines · 0 courses · 0 providers

Enable perspective shift and de-schematization

Facilitators should help patients use altered states to reconsider entrenched beliefs, habits, and self-referential frames. The paper describes LSD as promoting new perspectives, broader contextualization, and re-evaluation of illness, self, and life priorities.

1 care stage · 1 guidelines · 0 courses · 0 providers

Escitalopram monitoring and counseling

Understand the common and serious adverse effects, interaction risks, and monitoring needs of escitalopram. This includes cardiac, psychiatric, sexual, and withdrawal-related concerns.

2 care stages · 1 guidelines · 0 courses · 0 providers

Ethical data handling

Responsibility to use study information appropriately and in accordance with registry expectations. This includes respecting the limits of what can be inferred from the record text alone.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ethical handling of participant communication about future research

Manage optional future-contact procedures ethically and separately from current study participation. Participants may choose whether to authorize future contact without affecting present enrollment decisions.

2 care stages · 1 guidelines · 0 courses · 0 providers

Ethical purpose and intention setting

Organizers should clarify the purpose of the session and the ethical means of achieving it. They should also encourage participants to prepare an intention in an ethical and responsible way.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ethical risk communication

Communicates the experimental and unregulated nature of ibogaine treatment honestly. The source highlights an ibogaine subculture offering unregulated preparations, which creates an ethical duty to disclose uncertainty and risks.

2 care stages · 1 guidelines · 0 courses · 0 providers

Ethical use of nonstandard interventions

Uses a cautious, transparent ethical approach when working with an experimental or non-approved addiction treatment context.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ethical use of reassurance

Provide reassurance when it helps establish safety, while avoiding invalidation or minimization. Reassurance should support rather than dismiss the patient’s experience.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ethical use of trial information

Uses publicly available trial information responsibly and within its intended scope. Respects that registry content is not a substitute for clinical judgment, consent procedures, or study-specific training.

1 care stage · 1 guidelines · 0 courses · 0 providers

Explain likely effects of MDMA

Therapists should prepare participants by describing common psychological and physiological effects of MDMA and emphasizing variability of response.

1 care stage · 1 guidelines · 0 courses · 0 providers

Family or companion safety education

Therapists/facilitators should be able to educate companions about clinical warning signs and how to contact the study team. This extends monitoring beyond the clinic and supports rapid response to deterioration.

1 care stage · 1 guidelines · 0 courses · 0 providers

First-hand experiential training

The handbook explicitly states that therapists should understand the drug effects through personal experience, because direct familiarity improves empathy, guidance, and integration work. Staff who will interact with patients are ideally similarly trained.

1 care stage · 1 guidelines · 0 courses · 0 providers

Group facilitation and relational process leadership

Therapists and facilitators must be able to guide intentional group process in a way that supports safety, connection, and meaningful change. This includes managing both large- and small-group formats and maintaining a relationally anchored therapeutic environment.

2 care stages · 1 guidelines · 0 courses · 0 providers

Group risk escalation

Responds appropriately to safety threats disclosed in group therapy. Follows up on suicide, homicide, abuse, or neglect concerns and escalates when necessary.

1 care stage · 1 guidelines · 0 courses · 0 providers

Help patients generalize new coping responses

Therapists must teach patients to reactivate the acceptance, reduced fear, and interpersonal openness experienced during MDMA sessions when confronting later stressors. This helps convert acute session experiences into durable coping skills.

1 care stage · 1 guidelines · 0 courses · 0 providers

Home-practice coaching

Facilitator supports between-session practice and adherence to study procedures. Participants are expected to practice skills daily and complete smartphone-based EMA.

1 care stage · 1 guidelines · 0 courses · 0 providers

Hydration and electrolyte management

Providers must maintain hydration and avoid electrolyte depletion because dehydration and electrolyte abnormalities increase cardiac risk. Hydration is to be monitored before, during, and after treatment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Hydration management

Prevent dehydration during and after ibogaine treatment. The manual stresses that patients may not feel like drinking and that dehydration can become dangerous, especially if vomiting occurs.

3 care stages · 1 guidelines · 0 courses · 0 providers

Ibogaine treatment administration knowledge

Knows the use of ibogaine as a detoxification agent in medical and nonmedical settings and understands that its mechanism of action is novel and not fully established.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ibogaine treatment planning for opioid dependence

Understands ibogaine as an intervention used for opioid dependence and withdrawal management. Can align treatment planning with addiction severity and withdrawal status.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ibogaine-informed case selection

Can evaluate whether ibogaine is being considered in the context of a highly selected clinical case, based on the source’s description of a severe, treatment-refractory patient. This includes understanding the limited evidence base and the need for careful patient selection.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ibogaine-specific cardiac vigilance

Understand the unique cardiovascular hazards associated with ibogaine and the need for intensive cardiac oversight. The facilitator should know that cardiac risk is a central safety issue rather than a minor side effect.

2 care stages · 1 guidelines · 0 courses · 0 providers

Identity and values reconstruction

Facilitators must support the bereaved person in rebuilding identity and future orientation after loss. The protocol uses values clarification to help participants orient life around their own goals and surviving self.

1 care stage · 1 guidelines · 0 courses · 0 providers

Imaging and procedure-related awareness

Understands the implications of PET, MRI, blood sampling, and TMS-EEG procedures for participant comfort and safety. While not necessarily performing these procedures, the therapist/facilitator should know their risks and scheduling constraints.

2 care stages · 1 guidelines · 0 courses · 0 providers

Inclusivity and non-discrimination in participant engagement

Therapist/facilitator practice in the study must align with equity, diversity, and inclusion commitments by avoiding exclusions based on protected or social identity characteristics outside protocol-defined scientific/safety criteria. This supports ethically sound participant engagement.

2 care stages · 1 guidelines · 0 courses · 0 providers

Individual versus group modality selection

Therapists should understand the distinct advantages, limitations, and indications of individual and group methods. Clinical judgment is required to choose format, order, staffing, and group composition.

1 care stage · 1 guidelines · 0 courses · 0 providers

Informed consent administration

Therapists/facilitators must ensure participants are properly informed using approved consent materials before participation in MDMA-assisted psychotherapy research.

2 care stages · 1 guidelines · 0 courses · 0 providers

Informed consent and ethical use in uncertain evidence

Use ibogaine only after a careful discussion of uncertain efficacy, limited research, and known risks. Ethical practice requires transparent communication about the experimental nature of treatment and the absence of robust clinical standards.

3 care stages · 1 guidelines · 0 courses · 0 providers

Informed consent and experimental-treatment disclosure

Clearly explain the investigational nature of ibogaine treatment and its known serious risks before treatment begins. Ethical practice requires that patients understand both uncertain benefits and significant safety concerns.

2 care stages · 1 guidelines · 0 courses · 0 providers

Informed consent boundary awareness

Study personnel involved with participants must understand informed consent responsibilities and boundaries. Consent is an ongoing process, and appropriately trained staff without an existing clinical relationship obtain consent, not the PI.

2 care stages · 1 guidelines · 0 courses · 0 providers

Integrate experiences into daily life change

Therapists should help patients carry session experiences into durable changes in habits, relationships, values, and quality of life. Reported lasting effects included reduced anxiety, increased openness, patience, boundaries, and shifts in priorities.

2 care stages · 1 guidelines · 0 courses · 0 providers

Integrated pain-psychiatric care

Works with the combined clinical picture of chronic pain, depression, anxiety, and PTSD symptoms. Provides psychotherapy that is responsive to both somatic and psychiatric suffering.

2 care stages · 1 guidelines · 0 courses · 0 providers

Integration circle facilitation or referral

Facilitators should be able to host, moderate, or refer participants to integration circles and community support structures. These spaces help participants share experiences safely and confidentially.

1 care stage · 1 guidelines · 0 courses · 0 providers

Interpretation of autonomic effects

Understand that classic psychedelics can cause moderate increases in blood pressure, heart rate, temperature, and pupil size without necessarily indicating severe toxicity. Proper interpretation helps avoid overreaction while remaining vigilant.

1 care stage · 1 guidelines · 0 courses · 0 providers

Interpretation of neuroimaging-linked clinical findings

Understand that changes in cerebral blood flow were observed after ayahuasca intake in regions implicated in mood and emotion regulation. Facilitators should be able to contextualize these findings without overinterpreting them clinically.

2 care stages · 1 guidelines · 0 courses · 0 providers

Knowledge of ayahuasca and traditional Amazonian medicine

Understands the therapeutic role of ayahuasca as a psychoactive plant brew used ritually in traditional Amazonian medicine. Knowledge of the cultural and medicinal context is necessary to support safe and appropriate facilitation.

1 care stage · 1 guidelines · 0 courses · 0 providers

Knowledge of ibogaine pharmacology and anti-addiction rationale

Understand the basic rationale for ibogaine’s proposed effects in substance use disorders. This includes its reported ability to ease withdrawal, reduce craving, and act through multiple neurotransmitter systems.

1 care stage · 1 guidelines · 0 courses · 0 providers

Knowledge of psychedelic session structure

Facilitators need to understand the full treatment sequence and how each phase contributes to safety and treatment delivery. The intervention depends on correct sequencing and timing.

6 care stages · 1 guidelines · 0 courses · 0 providers

Knowledge of target population risks and context

Therapists need specific knowledge of methamphetamine use disorder, HIV risk behaviors, and the social context of affected populations to deliver relevant and responsive care. This includes understanding how methamphetamine use intersects with trauma, sexual risk, and HIV prevention or treatment adherence.

1 care stage · 1 guidelines · 0 courses · 0 providers

Knowledge of therapeutic mechanism and expected time course

The therapist/facilitator should know the expected onset, peak, and persistence of effects to guide monitoring and interpretation. The source reports acute effects with follow-up improvements lasting days.

4 care stages · 1 guidelines · 0 courses · 0 providers

Knowledge of toxicity profile and cardiac risk

Understand that ibogaine has a significant toxicity profile, especially cardiotoxicity. Fatalities have been temporally associated with use, often in the setting of medical comorbidity, co-use, or electrolyte imbalance.

1 care stage · 1 guidelines · 0 courses · 0 providers

Laboratory interpretation

Order, review, and interpret core laboratory studies relevant to ibogaine safety and metabolism. Competence includes recognizing abnormal values that increase risk or signal exclusion from treatment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Legal awareness

Those organizing sessions should understand the legal implications of ayahuasca in their jurisdiction. This helps them manage accountability and reduce legal risk.

2 care stages · 1 guidelines · 0 courses · 0 providers

Limits of confidentiality disclosure

Explains the boundaries of confidentiality so patients understand when information may be disclosed without permission. Applies legal and ethical duties related to safety, abuse, and mandated reporting.

1 care stage · 1 guidelines · 0 courses · 0 providers

Lost-to-follow-up procedures

The facilitator must make repeated documented efforts to contact participants who miss visits. Follow-up processes differ for responders and non-responders.

3 care stages · 1 guidelines · 0 courses · 0 providers

LSD psychotherapy administration

Ability to administer LSD in a psychotherapy setting using the regimen described in the source. The therapist/facilitator must understand session-based dosing and treatment course structure.

1 care stage · 1 guidelines · 0 courses · 0 providers

Maintain a post-session safety net

Therapists must provide continuity, availability, and clear support structures after MDMA sessions to reduce anxiety and manage emerging difficulties. This safety net extends beyond the dosing day.

5 care stages · 1 guidelines · 0 courses · 0 providers

Manage challenges with letting go and self-control

Therapists must help patients navigate early-session resistance, distrust, and discomfort related to surrendering usual control. Several participants reported temporary difficulty letting go or tolerating altered self-control.

1 care stage · 1 guidelines · 0 courses · 0 providers

Management of hypertension and cardiovascular complications

Therapists in this setting must recognize abnormal cardiovascular responses and follow protocolized responses for hypertensive crisis, angina, myocardial infarction, or stroke.

2 care stages · 1 guidelines · 0 courses · 0 providers

Management of psychological distress

Facilitators must be able to contain and support intense psychological distress during the session. The study notes that the experience could be emotionally difficult even when participants felt safe.

1 care stage · 1 guidelines · 0 courses · 0 providers

Managing short-duration high-intensity sessions

5-MeO-DMT produces a very short but intense experience, which changes facilitation demands. Facilitators must be prepared for rapid transitions into and out of the altered state.

5 care stages · 1 guidelines · 0 courses · 0 providers

Medical boundary awareness

Non-medical facilitators must not present themselves as medical professionals or provide medical advice. They should clearly state their limitations and encourage participants to consult their own healthcare providers when needed.

1 care stage · 1 guidelines · 0 courses · 0 providers

Medical contraindication screening

Recognizes medical factors that may increase risk during inhaled 5-MeO-DMT administration. Medical clearance is required before dosing.

4 care stages · 1 guidelines · 0 courses · 0 providers

Medical symptom monitoring and selective testing

Therapists/facilitators must monitor for adverse medical signs during sessions and obtain targeted testing when clinically indicated. Safety practice should balance participant comfort with symptom-triggered medical evaluation.

2 care stages · 1 guidelines · 0 courses · 0 providers

Medication and interaction review

Identify concurrent medications or recent drug exposures that may interact dangerously with ibogaine. The clinician/facilitator must understand that ibogaine can potentiate other drugs and that certain psychiatric medications or toxic agents may contraindicate treatment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Medication interaction screening

Screen for co-medications that may prolong QTc or affect CYP2D6 metabolism. This is critical to reduce confounding and prevent additive toxicity.

2 care stages · 1 guidelines · 0 courses · 0 providers

Medication reconciliation and interaction management

Therapists must understand clinically significant drug interactions with ibogaine, including QT-prolonging, serotonergic, centrally acting, and CYP2D6-related medications. This knowledge informs screening, tapering, and dosing decisions.

3 care stages · 1 guidelines · 0 courses · 0 providers

Mindfulness-based intervention knowledge

Facilitator must know the conceptual basis and components of MORE. The protocol links mindfulness, savoring, and reappraisal to changes in craving and reward processing.

1 care stage · 1 guidelines · 0 courses · 0 providers

Mindfulness-based stress reduction facilitation

Able to deliver or support an 8-week MBSR curriculum for clinical populations. This requires knowledge of mindfulness practices and the ability to adapt them to frontline healthcare providers experiencing depression and burnout.

1 care stage · 1 guidelines · 0 courses · 0 providers

Monitor symptom outcomes beyond PTSD

The protocol includes secondary outcomes for depression and anxiety severity, so clinicians should be able to assess and track these domains alongside PTSD symptoms. This broadens case monitoring and supports comprehensive clinical oversight.

2 care stages · 1 guidelines · 0 courses · 0 providers

Monitoring and documentation of device-related issues

Because study drug delivery uses a vaporization device, staff must be able to recognize, document, and escalate device deficiencies. Device issues may have safety implications even when no patient harm occurs.

2 care stages · 1 guidelines · 0 courses · 0 providers

MORE delivery

Facilitator can deliver Mindfulness-Oriented Recovery Enhancement (MORE) in an 8-week group format for patients with OUD. The intervention combines mindfulness training, cognitive reappraisal, and savoring techniques.

1 care stage · 1 guidelines · 0 courses · 0 providers

Motivational interviewing

Uses an open, collaborative MI style to engage participants and support change. Employs reflective listening, eliciting change talk, and reinforcing motivation without confrontation.

1 care stage · 1 guidelines · 0 courses · 0 providers

Narrative processing of grief

Facilitators need skill in helping bereaved individuals revisit and process the story of the loss in a tolerable and organized way. This includes working with traumatic or stressful memories while keeping the setting emotionally safe.

1 care stage · 1 guidelines · 0 courses · 0 providers

Nasal administration awareness

Understand the intranasal administration procedure and related local adverse effects. The facilitator must support safe delivery and monitor nasal reactions.

2 care stages · 1 guidelines · 0 courses · 0 providers

Neurologic adverse effect monitoring

Monitor for cerebellar toxicity and gait disturbance because severe transient ataxia was observed in all patients in the study. The facilitator must be able to detect impaired coordination and prevent falls or injury.

2 care stages · 1 guidelines · 0 courses · 0 providers

Non-leading symptom inquiry

Ask about symptoms and adverse effects in a neutral, non-suggestive manner. This reduces bias and improves safety detection in a vulnerable oncology population.

2 care stages · 1 guidelines · 0 courses · 0 providers

Non-restrictive physical protection

Facilitators must protect participants and others from harm without unnecessarily restraining the participant. The guidance emphasizes containing danger rather than restraining movement.

1 care stage · 1 guidelines · 0 courses · 0 providers

One-to-one interviewing

Facilitators should conduct individual interviews to understand the person, their motivations, and current condition. The interview also helps identify changes since any prior session.

1 care stage · 1 guidelines · 0 courses · 0 providers

Ongoing informed consent

Treat consent as a continuing process rather than a one-time event. Patients must understand the treatment and retain the ability to revoke consent, with special procedures during the medication session for safety.

5 care stages · 1 guidelines · 0 courses · 0 providers

Onset-phase reassurance and symptom redirection

During onset, therapists must help the subject stay relaxed, accept changes, and avoid fixation on somatic discomfort or irrelevant ideation. Music and reassurance are highlighted as practical tools for reducing fear and helping the subject welcome altered perception.

1 care stage · 1 guidelines · 0 courses · 0 providers

Operational prioritization of assessments

Sequences study procedures correctly to reduce bias and protect participant safety. Particularly prioritizes PROs, clinician ratings, and dosing-day procedures in the required order.

3 care stages · 1 guidelines · 0 courses · 0 providers

Opioid use disorder assessment

Understands the clinical profile of opioid use disorder and identifies individuals with opioid dependence who may be considered for ibogaine-based detoxification in observational or treatment settings.

1 care stage · 1 guidelines · 0 courses · 0 providers

Outcome interpretation in pilot research settings

Understands that findings from a pilot evaluation support feasibility and preliminary effectiveness rather than definitive efficacy. The facilitator should interpret outcomes cautiously and support structured data collection.

1 care stage · 1 guidelines · 0 courses · 0 providers

Overnight support role boundaries

Attendants and facilitators must maintain clear role boundaries, distinguishing supportive presence from psychotherapy or interpretation during overnight care.

1 care stage · 1 guidelines · 0 courses · 0 providers

Participant preparation and procedural guidance

Prepare participants for the dosing session and guide them through standardized procedures. The facilitator should ensure readiness, adherence to study rules, and smooth progression through the session schedule.

3 care stages · 1 guidelines · 0 courses · 0 providers

Participant safety awareness

Maintains awareness that any clinical trial context may involve participant risk and requires appropriate safeguards. Even minimal source text implies the need for cautious, non-assumptive practice.

1 care stage · 1 guidelines · 0 courses · 0 providers

Participant screening and selection

Clinicians must identify appropriate participants and recognize that the study enrolled psychiatrically healthy nicotine-dependent smokers. Competence includes screening for psychiatric suitability and tobacco dependence characteristics relevant to treatment eligibility.

1 care stage · 1 guidelines · 0 courses · 0 providers

Participant-centered inclusion and non-discrimination

The protocol explicitly frames equity, diversity, and inclusion as ethical requirements. Facilitators should deliver care and study procedures without discrimination on race, ethnicity, religion, sex, or gender.

1 care stage · 1 guidelines · 0 courses · 0 providers

Patient rights advocacy

Facilitators must uphold the Ibogaine Patient’s Bill of Rights, including dignity, privacy, access to information, and complaint processes. The provider should support interpretation and grievance handling when needed.

1 care stage · 1 guidelines · 0 courses · 0 providers

Patient selection and indication awareness

Knowledge of the patient populations and symptom profiles for which KAP may be considered, particularly depression, anxiety, PTSD, and treatment-resistant presentations. The article highlights benefit across a wide variety of diagnoses, with notable improvement in depression and anxiety.

1 care stage · 1 guidelines · 0 courses · 0 providers

Patient selection and risk awareness

Applies cautious patient selection when considering ibogaine for opioid detoxification, particularly for individuals with refractory opioid use disorder.

1 care stage · 1 guidelines · 0 courses · 0 providers

Permission for full expression

Participants must be given complete permission to express what arises without shame, fear, or guilt. The facilitator should accept the unfolding nonjudgmentally and avoid pathologizing it.

1 care stage · 1 guidelines · 0 courses · 0 providers

Pharmacokinetic literacy

Understands core pharmacokinetic concepts needed to interpret study findings and guide safety observation. Recognizes dose-linear exposure changes and elimination characteristics relevant to monitoring windows.

2 care stages · 1 guidelines · 0 courses · 0 providers

Pharmacokinetic understanding of ibogaine

Understand ibogaine, noribogaine, and noribogaine glucuronide disposition and how exposure relates to clinical effects. This knowledge supports safe interpretation of observed toxicity and response.

1 care stage · 1 guidelines · 0 courses · 0 providers

Placebo and control-condition literacy

Knowledge of placebo-controlled treatment design and the interpretive issues it raises in psychotherapy research. This supports appropriate understanding of efficacy findings.

1 care stage · 1 guidelines · 0 courses · 0 providers

Placebo and expectancy awareness

Recognize that placebo response can be substantial in depression trials and that supportive care may amplify expectancy effects. Facilitators should avoid unintentionally inflating suggestibility beyond the protocol.

1 care stage · 1 guidelines · 0 courses · 0 providers

Practitioner background verification

The facilitator should be able to clearly describe their history, experience, and specific approach with 5-MeO-DMT or related sacramental work. Participants should be able to assess whether the practitioner’s background, lineage, or training is appropriate for their needs.

1 care stage · 1 guidelines · 0 courses · 0 providers

Pre-session medical screening

The therapist/facilitator must ensure medical suitability before ayahuasca administration by checking for conditions that increase risk. Screening should include physical exam, laboratory testing, and pregnancy assessment when indicated.

3 care stages · 1 guidelines · 0 courses · 0 providers

Product identity verification

Verify the formulation and potency of the ibogaine product before administration. The manual warns that confusion between HCl, extract, and root bark can cause underdosing or fatal overdosing.

2 care stages · 1 guidelines · 0 courses · 0 providers

Professional conduct around sexuality and kundalini energy

Facilitators may witness intense sensual, sexual, or kundalini energy but must respond professionally and without reciprocation or exploitation. Emotional maturity and decorum are required to protect participant vulnerability.

1 care stage · 1 guidelines · 0 courses · 0 providers

Professional ethics and policy adherence

Adheres to organizational code of ethics, privacy policy, electronic communication policy, and applicable laws. Maintains professional conduct across contractor and clinic arrangements.

2 care stages · 1 guidelines · 0 courses · 0 providers

Professional training in human subjects research

Expectation that study personnel are trained in research ethics and responsible conduct of research. This underpins appropriate consent, confidentiality, and participant safety practices.

2 care stages · 1 guidelines · 0 courses · 0 providers

Protocol adherence and dose conditions

Follows the study's operational rules for dose timing, progression, and stopping conditions. Reliable execution is necessary for both safety and interpretability of results.

3 care stages · 1 guidelines · 0 courses · 0 providers

Protocol-specific competency identification

Can determine whether a study record actually specifies therapist/facilitator responsibilities or competencies. This includes distinguishing direct treatment skills from administrative registry instructions.

1 care stage · 1 guidelines · 0 courses · 0 providers

Provide structured psychological support alongside treatment

All patients in the trial received psychological support in conjunction with medication administration, indicating that facilitators must be able to deliver structured supportive care as part of the treatment model.

2 care stages · 1 guidelines · 0 courses · 0 providers

Psychedelic pharmacology and interaction awareness

Understand the pharmacology and interaction risks of 5-MeO-DMT/BPL-003, including serotonergic and cardiovascular concerns. This knowledge informs safe preparation, exclusion screening, and monitoring.

4 care stages · 1 guidelines · 0 courses · 0 providers

Psychiatric assessment using structured interviews

Conduct or support psychiatric screening using clinical interviews and structured diagnostic tools. The goal is to establish baseline mental health status and detect exclusionary disorders or instability.

2 care stages · 1 guidelines · 0 courses · 0 providers

Psychology- and resilience-informed curriculum delivery

Facilitators need knowledge of a structured curriculum informed by psychology and resilience science. They must be able to teach and reinforce core resilience factors and translate them into experiential group practices.

1 care stage · 1 guidelines · 0 courses · 0 providers

Psychotherapy discussion and support

Provides required discussion of psychotherapy before randomization and supports continuation of clinically indicated non-study psychotherapy. Documents participant choice and any psychotherapy-related decisions.

1 care stage · 1 guidelines · 0 courses · 0 providers

Recognition of contextual limitations

The facilitator should understand that effects observed in a controlled clinical setting may differ from those in ceremonial or ritual contexts. This awareness shapes interpretation and informs safer translation to other settings.

2 care stages · 1 guidelines · 0 courses · 0 providers

Recognition of contraindications and medication interactions

Facilitators need knowledge of conditions and medications that may make 5-MeO-DMT unsafe or inappropriate. They should identify possible interactions and discuss them clearly before participation.

2 care stages · 1 guidelines · 0 courses · 0 providers

Recognition of limitations and uncertainty in psychedelic support

Facilitators should be aware that outcome variability may reflect both drug effects and psychological support effects. The source notes that fidelity was not assessed, underscoring the need for humility and careful practice.

1 care stage · 1 guidelines · 0 courses · 0 providers

Recognition of participant functional status and recovery

Facilitators should understand that treatment aims include symptom reduction and improved functioning. Support work should attend to both emotional processing and real-world disability.

2 care stages · 1 guidelines · 0 courses · 0 providers

Recognize and support vulnerability under altered states

Because participants may be more suggestible during psychedelic sessions, therapists must actively protect against manipulation and unsafe influence. This requires vigilance and careful conduct.

2 care stages · 1 guidelines · 0 courses · 0 providers

Recruitment and contact ethics

Ability to recruit participants using approved procedures while respecting privacy, documented preferences, and limits on contact attempts. Recruitment must avoid coercion and unauthorized disclosure.

1 care stage · 1 guidelines · 0 courses · 0 providers

Registry data compliance awareness

Awareness of the need to use official data element definitions when submitting registration or results information. This reflects adherence to accurate and compliant trial reporting practices.

1 care stage · 1 guidelines · 0 courses · 0 providers

Regulatory information handling

Responsibility to treat study information in a manner consistent with registration and results-reporting requirements. This includes using official definitions rather than improvising field content.

1 care stage · 1 guidelines · 0 courses · 0 providers

Relapse-prevention support

Help patients navigate craving, relapse risk, and post-treatment vulnerability. The manual notes that fear of relapse is more realistic than fear of withdrawal after ibogaine.

3 care stages · 1 guidelines · 0 courses · 0 providers

Research visit scheduling and follow-up coordination

Coordinate multi-visit assessment timelines around the psilocybin session. Follow-up data collection is essential for longitudinal outcomes and requires careful scheduling.

3 care stages · 1 guidelines · 0 courses · 0 providers

Research-aware clinical practice

Knowledge of clinical trial methods and evaluation approaches relevant to psychotherapy research. The source indicates controlled clinical trial and analysis of variance contexts.

1 care stage · 1 guidelines · 0 courses · 0 providers

Research-professional role separation

Distinguish psychotherapy/facilitation functions from outcome assessment and other research tasks. Separation reduces bias and protects the integrity of blinded assessments.

3 care stages · 1 guidelines · 0 courses · 0 providers

Residential addiction treatment facilitation

Able to function within an inpatient rehabilitation setting for substance-related disorders. The facilitator must support the structured residential environment and care of patients with addiction comorbidity.

1 care stage · 1 guidelines · 0 courses · 0 providers

Risk and contraindication screening

Facilitators must know the risks and contraindications associated with ayahuasca use. They should identify medical and psychological factors that make participation unsafe or require extra caution.

2 care stages · 1 guidelines · 0 courses · 0 providers

Risk education and expectation setting

Can explain common, psychological, and severe risks of KAP in understandable terms. Sets realistic expectations that outcomes may vary and are not guaranteed.

2 care stages · 1 guidelines · 0 courses · 0 providers

Risk management for vulnerable bereaved participants

Therapists must monitor a clinically vulnerable population experiencing recent loss and possible PGD risk. The protocol requires special attention to psychological destabilization, distress, and functional impairment.

2 care stages · 1 guidelines · 0 courses · 0 providers

Route-of-administration awareness

The facilitator should understand the administration context for the intervention. The source highlights inhalation as the studied route and its rapid onset.

1 care stage · 1 guidelines · 0 courses · 0 providers

Route-specific administration awareness

Facilitators need working knowledge of administration routes because onset, duration, intensity, and tolerability vary substantially. This informs preparation, monitoring, and participant education.

3 care stages · 1 guidelines · 0 courses · 0 providers

Safe physical intervention awareness

If physical intervention is needed, it must be done carefully to reduce risk such as choking or aspiration. The facilitator should understand safer alternatives and avoid dangerous techniques.

1 care stage · 1 guidelines · 0 courses · 0 providers

Sedation and comfort management

Recognize when post-session exhaustion or discomfort may warrant supportive symptom management and understand the limited use of sedatives in the protocol. The facilitator must balance comfort with safety and document any sedating agents used.

1 care stage · 1 guidelines · 0 courses · 0 providers

Sedation judgment

Decide when sedation is appropriate and select agents that have been used safely in the manual’s reports. Sedation is presented as optional and patient-specific, not routine.

1 care stage · 1 guidelines · 0 courses · 0 providers

Session closure control

Participants should not leave before the session is formally closed. Facilitators must check stability before ending the session.

1 care stage · 1 guidelines · 0 courses · 0 providers

Session format competence

Facilitators should understand how to work in one-on-one, group, and advanced simultaneous group formats. They must clearly explain the context, method, and risks of their chosen format.

1 care stage · 1 guidelines · 0 courses · 0 providers

Session-day eligibility and compliance checks

Clinicians must ensure participants meet day-of-session safety requirements before psilocybin is administered. This includes verifying toxicology, pregnancy, alcohol abstinence, and adherence to protocol restrictions.

3 care stages · 1 guidelines · 0 courses · 0 providers

Set shaping and mindset influence

The facilitator influences the participant’s mindset through tone, language, responsiveness, and overall presence. They should intentionally support a conducive mental set from first contact through post-session care.

2 care stages · 1 guidelines · 0 courses · 0 providers

Short-duration session management

The facilitator should be able to manage a brief but intense treatment window. The source suggests a shorter-acting psychedelic may enable rapid onset of response and reduce burden compared with longer-acting agents.

3 care stages · 1 guidelines · 0 courses · 0 providers

Silence and strategic dialogue

Facilitators should know when silence is best and when brief dialogue can help orient or reassure. Words should be used sparingly, precisely, and with awareness of their power.

1 care stage · 1 guidelines · 0 courses · 0 providers

Source extraction not possible

The provided source text does not contain the article content needed to identify therapist or facilitator competencies. It only includes a Wiley cookie/login page and site boilerplate.

1 care stage · 1 guidelines · 0 courses · 0 providers

Structured psychiatric screening collaboration

Understands the screening instruments and the respective roles of site staff and independent raters. The facilitator must collaborate with rater findings while maintaining appropriate boundaries and blinding.

1 care stage · 1 guidelines · 0 courses · 0 providers

Study design integrity

Supports rigorous conduct of randomized controlled safety studies by maintaining protocol adherence and minimizing bias. Protects the validity of safety, tolerability, and exploratory efficacy assessments.

3 care stages · 1 guidelines · 0 courses · 0 providers

Subpsychedelic 5-MeO-DMT administration

Administers repeated sublingual microdoses of 5-MeO-DMT in a controlled clinical trial setting. Must follow the assigned dose schedule and maintain blinding across active and placebo conditions.

1 care stage · 1 guidelines · 0 courses · 0 providers

Substance composition and batch awareness

Know that ayahuasca composition can vary and that chemical characterization matters. Facilitators or clinical teams should understand the potency and stability of the administered brew.

2 care stages · 1 guidelines · 0 courses · 0 providers

SUDS-guided exposure monitoring

Use Subjective Units of Distress Scale ratings to track fear activation and extinction during PE sessions. This requires eliciting reliable distress ratings and using them to guide exposure processing.

2 care stages · 1 guidelines · 0 courses · 0 providers

Support confrontation with existential anxiety

Therapists should be able to help patients face anxiety, fear of death, hopelessness, and suffering associated with life-threatening illness. The treatment context explicitly targets existential distress and uses LSD sessions to engage these themes.

1 care stage · 1 guidelines · 0 courses · 0 providers

Support for multiplicity without pathologizing

Therapists should understand multiplicity of the psyche as a normal phenomenon that may become more apparent in trauma treatment and altered states. They must respond with curiosity and support rather than pathologizing parts, selves, or dissociative phenomena unless clinically necessary.

1 care stage · 1 guidelines · 0 courses · 0 providers

Support for multiplicity/parts

Therapists must understand that parts, selves, subpersonalities, or dissociative-like multiplicity can emerge normally, especially in trauma. They should not pathologize these experiences and should help use them therapeutically.

1 care stage · 1 guidelines · 0 courses · 0 providers

Support for spontaneous somatic expression

Participants may express the medicine through shaking, curling, dancing, screaming, glossolalia, orgasm, or other intense bodily responses. The facilitator should recognize these as possible natural responses and support them appropriately.

1 care stage · 1 guidelines · 0 courses · 0 providers

Support positive and corrective emotional experiences

Therapists must also recognize and deepen beneficial states such as joy, self-affirmation, resolution, empathy, forgiveness, and acceptance. These experiences are treated as therapeutically important, not merely incidental.

1 care stage · 1 guidelines · 0 courses · 0 providers

Support relationship and support-system integration

Therapists must help participants navigate interpersonal shifts, disclosure decisions, and support-system responses during healing. They should anticipate misunderstanding, family-system changes, and new relational capacities.

2 care stages · 1 guidelines · 0 courses · 0 providers

Supportive context design

The article indicates that a structured, supportive context is associated with more positive acute and enduring effects and fewer challenging experiences. Facilitators should actively design the session context around safety and support.

2 care stages · 1 guidelines · 0 courses · 0 providers

Supportive presence selection and visibility

Facilitators should adapt their visibility and distance to best support the participant, sometimes being visually present and sometimes minimizing their presence. The goal is to provide reassurance without becoming the focus of attachment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Task instruction and coaching

Prepare participants to complete emotional processing tasks and questionnaires accurately. Staff must teach task procedures and ensure participants understand expectations before scanning and follow-up assessments.

3 care stages · 1 guidelines · 0 courses · 0 providers

Team coordination and protocol adherence

Operate within a shared management plan so that all team members respond consistently during routine care and emergencies. The guideline emphasizes coordinated actions, not ad hoc improvisation.

1 care stage · 1 guidelines · 0 courses · 0 providers

Telephone eligibility screening

Ability to conduct initial phone-based screening to determine whether a potential participant appears eligible for the protocol. This requires efficient, accurate triage before in-person assessment.

1 care stage · 1 guidelines · 0 courses · 0 providers

Timing and calibration of interventions

A key applied skill is knowing when to remain silently present, when to inquire, and when to offer more active guidance. Effective work depends on moment-to-moment attunement to verbal, nonverbal, historical, and pharmacological cues.

1 care stage · 1 guidelines · 0 courses · 0 providers

Training and supervision compliance

Operate only within the bounds of formal training, supervision, and site authorization. The protocol expects specialized training for facilitators, raters, and all staff interacting with participants or data.

1 care stage · 1 guidelines · 0 courses · 0 providers

Trauma-informed case conceptualization

Understand PTSD, complex trauma, avoidance, dissociation, attachment disruption, and moral injury in order to interpret clinical material accurately and flexibly. Diagnosis-specific knowledge informs judgment without making the treatment protocol rigid.

1 care stage · 1 guidelines · 0 courses · 0 providers

Trauma-informed, non-threatening interviewing

Use a caring, natural, and non-threatening interview style to assess psychiatric and psychological domains. The protocol emphasizes normalization, reduction of guilt, symptom exaggeration techniques, and a logical flow that facilitates rapport.

2 care stages · 1 guidelines · 0 courses · 0 providers

Understanding of bipolar-specific risk context

The facilitator must understand why bipolar II participants require enhanced monitoring and conservative dosing. The protocol is built around the risk of mood destabilization in this population.

4 care stages · 1 guidelines · 0 courses · 0 providers

Use and training of overnight attendants

Facilitators must coordinate appropriate overnight support personnel and ensure they are trained for the role. Attention to participant comfort and boundaries is built into staffing decisions.

1 care stage · 1 guidelines · 0 courses · 0 providers

Use clinical judgment for intervention timing

Therapists must skillfully decide when to facilitate, when to redirect, and when to silently witness. Effective treatment requires balancing guidance with respect for the patient’s self-directed inner healing process.

1 care stage · 1 guidelines · 0 courses · 0 providers

Use of cognitive and behavioral assessment domains

Understand the domains assessed in the Storyline psychiatric and neurological interviews and use this knowledge to support accurate administration and interpretation of study tasks. Domains include cognition, mood, homeostasis, social support, and psychosis/suicidality screening.

4 care stages · 1 guidelines · 0 courses · 0 providers

Use of music, chant, sound, and aroma

Facilitators may use sound and scent intentionally to support launch, peak, and re-entry, but these modalities must never become distracting. They need judgment about timing, dosage, and participant responsiveness.

1 care stage · 1 guidelines · 0 courses · 0 providers

Use of non-IV delivery model

Knowledge that KAP may be delivered without intravenous access and that non-IV office-based use is part of the described practice model. This reflects a shift from IV-only psychiatric use to broader administration approaches.

2 care stages · 1 guidelines · 0 courses · 0 providers

Use patient-reported outcomes in clinical evaluation

The study relied on self-reported symptomatology, so clinicians should understand how to gather and interpret patient-reported outcomes relevant to psychiatric and existential distress. This includes using subjective reports as meaningful indicators while recognizing their limits.

2 care stages · 1 guidelines · 0 courses · 0 providers

Use self-directed enquiry

Help participants direct attention to their own present-moment internal experience and explore it from multiple perspectives. This is practiced in preparation and used to support participants if challenging material emerges during dosing.

3 care stages · 1 guidelines · 0 courses · 0 providers

Validate difficult experiences as healing

Therapists should frame difficult emotions, challenging material, and distressing experiences as potentially meaningful parts of healing rather than signs of failure.

2 care stages · 1 guidelines · 0 courses · 0 providers

Vital sign and clinical observation awareness

Understand the expected acute physiological effects of BPL-003 and monitor for clinically meaningful changes. The facilitator should recognize that transient blood pressure and heart rate increases may occur.

3 care stages · 1 guidelines · 0 courses · 0 providers

Withdrawal and craving support

Monitor and address nicotine withdrawal symptoms and smoking urges across the treatment window. Facilitators help participants manage discomfort and sustain abstinence through high-risk periods.

2 care stages · 1 guidelines · 0 courses · 0 providers

Withdrawal symptom management

Support patients through acute opioid withdrawal during ibogaine treatment when withdrawal symptoms are present. The source describes use of oral hydromorphone for symptom relief within the protocol.

1 care stage · 1 guidelines · 0 courses · 0 providers

Work skillfully with resistance and protective mechanisms

Therapists should respect defenses, protectors, and resistance as potentially adaptive rather than obstacles to be forcibly overcome. The skill lies in fostering awareness and curiosity about protection while minimizing retraumatization.

1 care stage · 1 guidelines · 0 courses · 0 providers

Work with emotion regulation and cognitive schemas

Therapists should understand and address cognitive-affective mechanisms linked to improvement, particularly emotion regulation and positive and negative cognitive schemas. The study associated symptom improvement with changes in these domains.

1 care stage · 1 guidelines · 0 courses · 0 providers

Work within randomized controlled trial and blinding procedures

Because this is a randomized controlled trial comparing ketamine with active placebo, clinicians must respect trial procedures that protect scientific integrity and participant welfare. This includes adherence to allocation procedures and avoiding actions that could compromise blinding.

1 care stage · 1 guidelines · 0 courses · 0 providers

Case-based practice, peer consultation, and professional learning community

Teaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.

8 care stages · 0 guidelines · 8 courses · 7 providers

Psychedelic therapy foundation

Cluster covering 7 related competencies including: Psychedelic therapy foundation, Psychedelic therapy foundations, Psychedelic practice fundamentals.

4 care stages · 0 guidelines · 6 courses · 5 providers

Neurobiology of non-ordinary states

Teaches the neurobiological basis of psychedelic and non-ordinary states, including default mode, salience, fear, and related brain-network models. The competency links altered-state phenomenology with therapeutic mechanisms and clinical implications.

5 care stages · 0 guidelines · 4 courses · 4 providers

Ethics and ethical practice

Cluster covering 4 related competencies including: Ethical practice, Ethics in psychedelic care, Ethics and ethical practice.

8 care stages · 0 guidelines · 4 courses · 3 providers

Clinical protocol literacy

Teaches practitioners to read and understand clinical protocols, treatment manuals, and evidence-based psychedelic care procedures. The focus is knowing how protocol requirements shape preparation, dosing, integration, documentation, and safety responsibilities.

5 care stages · 0 guidelines · 2 courses · 2 providers

Experiential Learning and Reflective Practice

Teaches practitioners to use experiential exercises, embodied awareness, supervision, and structured self-reflection to examine their own reactions, assumptions, limits, and relational patterns in clinical work.

3 care stages · 0 guidelines · 2 courses · 2 providers

Preparation and therapeutic alliance

Cluster covering 2 related competencies including: Preparation and therapeutic alliance, Preparation and therapeutic alliance building.

5 care stages · 0 guidelines · 2 courses · 2 providers

Professional application and practice development

Teaches practitioners how to translate psychedelic-informed training into professional practice, including applied skill development, scope awareness, practice-building considerations, and integration of competencies into real clinical or wellness settings.

4 care stages · 0 guidelines · 2 courses · 2 providers

Complex-case support and ethics-based clinical judgment

Teaches work with clinically complex contexts such as trauma, palliative care, and other nuanced presentations where ethical judgment, scope discipline, careful assessment, and individualized support are required.

3 care stages · 0 guidelines · 2 courses · 1 providers

Dosing-session framework

Cluster covering 2 related competencies including: Dosing-session framework, Dosing-session framework use.

3 care stages · 0 guidelines · 2 courses · 1 providers

Legal access pathways and care-team coordination

Teaches how participants move through lawful access routes and coordinated care pathways. The competency covers referral navigation, team handoffs, and the practical steps needed to connect eligible participants with appropriate treatment or study settings.

5 care stages · 0 guidelines · 2 courses · 1 providers

Active guiding and purposeful intervention

The course also teaches a more active guiding style, especially through Ralph Metzner’s approach, where guides may introduce focused inquiries, somatic practices, or other interventions. Learners are shown how interventions can shape the trajectory of a session when used skillfully.

3 care stages · 0 guidelines · 1 courses · 1 providers

Apprenticeship and mentor shadowing

The program includes supervised apprenticeship hours with pre-approved mentors. Learners are expected to observe, assist, and translate training into supervised practice.

6 care stages · 0 guidelines · 1 courses · 1 providers

Assessment and intake

The curriculum includes practical assessment work and use of intake templates and assessment forms. Students learn to evaluate client fit and tailor support based on client goals and needs.

3 care stages · 0 guidelines · 1 courses · 1 providers

Clinical trial training and feedback use

The page highlights best-in-class clinical training for drug trials and AI-supported evaluation. Learners are expected to refine skills quickly and receive targeted feedback in training or evaluation contexts.

8 care stages · 0 guidelines · 1 courses · 1 providers

Collaborative-care role awareness

The program emphasizes that it prepares people for therapeutic and facilitative roles within a collaborative care framework, not independent medical practice. Learners are expected to understand role boundaries, especially around prescribing and administration.

5 care stages · 0 guidelines · 1 courses · 1 providers

Compound comparison for therapeutic use

The course teaches learners to distinguish between classic psychedelics and emerging therapies within therapeutic applications. This is a foundational comparative literacy competency rather than a protocol-specific skill.

6 care stages · 0 guidelines · 1 courses · 1 providers

Contemplative practice support

Contemplative practice is included as a core domain, suggesting learners are exposed to practices that support presence, reflection, and self-regulation in facilitation work. This likely supports both practitioner preparation and client-facing care.

4 care stages · 0 guidelines · 1 courses · 1 providers

Coordination and documentation using checklists and manuals

The page repeatedly points learners to manuals, checklists, PDFs, and reference materials, indicating a practical emphasis on coordination and structured preparation. This suggests learners should be able to organize session materials and support process consistency.

4 care stages · 0 guidelines · 1 courses · 1 providers

Debriefing and reflective practice

The practicum includes retreat team debriefs, supervisor meetings, and assessment presentations. This signals an expectation that learners can reflect on practice, receive feedback, and integrate learning.

6 care stages · 0 guidelines · 1 courses · 1 providers

Equitable Access and Inclusive Service Delivery

Teaches providers to recognise access barriers and health disparities, adapt services for diverse participant needs, and deliver care in ways that are inclusive, accessible, culturally responsive, and practically reachable.

3 care stages · 0 guidelines · 1 courses · 1 providers

Ethical and equitable practice

Learners are expected to follow the North Star Ethics Pledge and practice non-discrimination, equity, and inclusion. Ethical responsibility is positioned as a core professional competency.

2 care stages · 0 guidelines · 1 courses · 1 providers

Ethical decision-making and confidentiality

The practicum explicitly says sites cover ethical considerations such as confidentiality, privacy, professional conduct, and ethical decision-making. Ethical alignment is also part of site approval.

2 care stages · 0 guidelines · 1 courses · 1 providers

Ethical grounding and integrity

The course repeatedly emphasizes ethical considerations, safety, and integrity in practice. Learners are expected to develop a grounded professional stance that respects legal boundaries and participant welfare.

3 care stages · 0 guidelines · 1 courses · 1 providers

Expanded-state therapeutic skills

The course explicitly teaches techniques for working with patients in altered states, including grounding, breathwork, and mindfulness. These are presented as tools for supporting expanded and ordinary states of consciousness.

2 care stages · 0 guidelines · 1 courses · 1 providers

Human-centred, experiential facilitation

The overall program emphasizes experiential, relational, and community-grounded learning, including retreat and practicum components. Learners are expected to develop a grounded facilitation presence in addition to theory.

4 care stages · 0 guidelines · 1 courses · 1 providers

Justice, diversity, and inclusion practice

JEDI is explicitly named as part of the program structure and curriculum. Learners are expected to examine systemic marginalization, positionality, and power while building more inclusive psychedelic services.

1 care stage · 0 guidelines · 1 courses · 1 providers

Leadership and coaching presence in expanded states

Faculty and program structure emphasize leadership, coaching presence, and personal transformation as part of practitioner development. Students are expected to become more skillful in guiding high-achieving and growth-oriented clients.

4 care stages · 0 guidelines · 1 courses · 1 providers

Mentorship and professional development

Each trainee works with a mentor, and mentoring includes professional development discussions, role plays, and networking. This indicates structured support for building practice readiness and professional identity.

3 care stages · 0 guidelines · 1 courses · 1 providers

Microdosing and macrodosing protocol design

Learners are taught to design custom protocols for both microdosing and macrodosing based on client goals. The page also references microdosing formulas and practical application of timing and dosage nuances.

4 care stages · 0 guidelines · 1 courses · 1 providers

Observing and holding space without reacting

Learners are expected to develop the ability to witness clients and processes calmly, without overreacting or trying to control the experience. The course explicitly frames this as foundational to practitioner development.

4 care stages · 0 guidelines · 1 courses · 1 providers

Peer consultation and collaborative learning

Vital emphasizes study groups, peer interaction, and faculty-led sessions. Learners are expected to collaborate with others, receive feedback, and improve their practice through community learning.

4 care stages · 0 guidelines · 1 courses · 1 providers

Peer-informed clinical judgment

The course emphasizes learning from experienced trainers and a community of peers, suggesting development of clinical judgment through discussion, feedback, and shared practice. This is framed as part of building competence in an evolving field.

1 care stage · 0 guidelines · 1 courses · 1 providers

Personal growth work and self-exploration

Students are expected to complete personal growth work outside the program, including therapy, guided entheogenic work, or meditation retreats. This signals the importance of self-awareness and personal preparation for facilitation work.

2 care stages · 0 guidelines · 1 courses · 1 providers

Professional development and directory readiness

Learners are guided to earn badges and join a professional directory, showing an emphasis on professional identity, discoverability, and readiness to be found by clients and industry leaders. This is a practice-facing career competency rather than a clinical one.

2 care stages · 0 guidelines · 1 courses · 1 providers

Professional identity and licensing readiness

The page repeatedly frames the program as preparing learners for licensure and professional practice in Oregon. Learners are expected to understand practice context, licensure requirements, and professional transitions.

3 care stages · 0 guidelines · 1 courses · 1 providers

Reciprocity and ecological awareness

Reciprocity and ecological awareness are named as a core knowledge domain. This indicates training in relational responsibility, environmental context, and respectful exchange with communities and traditions.

1 care stage · 0 guidelines · 1 courses · 1 providers

Referral and further-training planning

The workshop provides recommendations for obtaining further training, signaling a competency in identifying next-step education and appropriate escalation pathways. This supports responsible scope-of-practice decisions.

1 care stage · 0 guidelines · 1 courses · 1 providers

Respond ethically and relationally in crisis

The course explicitly includes ethical and relational considerations in crisis response. This suggests learners are trained to act with care, boundaries, and attunement when responding to acute distress.

3 care stages · 0 guidelines · 1 courses · 1 providers

Ritual closing and cleansing

The training includes practices for cleansing and closing psychedelic sessions appropriately. This signals competence in ending sessions in a structured, culturally responsive way.

3 care stages · 0 guidelines · 1 courses · 1 providers

Safety and legal boundaries awareness

The page includes explicit warnings about what graduates can and cannot legally do. Learners are expected to understand scope limits, licensure requirements, and when consultation supervision is needed.

3 care stages · 0 guidelines · 1 courses · 1 providers

Safety-oriented documentation and templates

Trainees receive templates such as consent and intake forms, informational documents, and guidelines, which implies competence in using standardized practice materials. The page also signals procedural support for safe and organized care delivery.

5 care stages · 0 guidelines · 1 courses · 1 providers

Safety, ethics, and responsibility in expanded states work

The course explicitly states that facilitators are guided in safety, ethics, and responsibility. Learners are expected to recognize and manage the unique risks of working with altered states.

6 care stages · 0 guidelines · 1 courses · 1 providers

Space preparation and ceremonial setup

Practicum hours may include operational tasks like preparing rooms, setting up altars, and arranging ceremonial spaces. These are treated as part of hands-on professional competence.

3 care stages · 0 guidelines · 1 courses · 1 providers

Structured PAP process navigation

The course teaches the overall PAP workflow from screening through follow-up. Learners are expected to understand and explain each phase of treatment in a structured way.

7 care stages · 0 guidelines · 1 courses · 1 providers

Supervised experiential practice

A defining feature of the training is hands-on experiential practice in both non-substance and substance-based modalities under supervision. Learners practice patient and therapist roles, facilitating and undergoing sessions in a structured learning context.

5 care stages · 0 guidelines · 1 courses · 1 providers

Supervised practicum and feedback integration

Students complete 50 supervised practicum hours and receive expert feedback while working with real clients. This is intended to translate theory into competent applied practice.

7 care stages · 0 guidelines · 1 courses · 1 providers

Supporting diverse spiritual and community contexts

The program states it prepares facilitators to address the needs of clients, patients, or community members from diverse faith traditions and communities of origin. Learners are expected to adapt facilitation to varied settings and worldviews.

5 care stages · 0 guidelines · 1 courses · 1 providers

Therapeutic technique enhancement

Vital says learners will expand their skills and enhance therapeutic techniques. This suggests training in improving how they support clients in psychedelic-related therapeutic work.

4 care stages · 0 guidelines · 1 courses · 1 providers

Tracking nervous systems and consent dynamics

The Colorado practicum site explicitly teaches relational competence, including tracking nervous systems, power, and consent dynamics moment by moment. This is presented as a core facilitation capability.

4 care stages · 0 guidelines · 1 courses · 1 providers

Use of complementary support methods

Students explore how psychedelics can be integrated with supportive methods such as breathwork, meditation, cold therapy, and neurofeedback. The course emphasizes a holistic toolkit rather than a single-method approach.

4 care stages · 0 guidelines · 1 courses · 1 providers

Use structured preparedness frameworks

The course is positioned as a preparedness-oriented training with self-directed preparation plus live facilitated learning. Learners are expected to internalize a framework for managing challenging or crisis moments with confidence and care.

2 care stages · 0 guidelines · 1 courses · 1 providers

Working within legal and approved site structures

The practicum requires placements at pre-approved sites and emphasizes legal and ethical standards. Learners are exposed to different settings, including clinical, retreat, and harm reduction organizations.

3 care stages · 0 guidelines · 1 courses · 1 providers

Bilingual and bicultural engagement

The page explicitly signals the value of bilingual and bicultural heritage as a foundation for practice. This points to competence in communicating and relating across language and cultural context.

4 care stages · 0 guidelines · 0 courses · 1 providers

Hybrid in-person and virtual session support

The course teaches students to guide both in-person and online sessions, including the technical skills needed for virtual facilitation. It explicitly notes that online training includes learning tech skills to become a confident virtual guide.

4 care stages · 0 guidelines · 0 courses · 1 providers

Therapeutic support in patient care settings

The page highlights extensive patient care experience and a background in holistic counseling psychology, suggesting practical competence in supporting participants in clinical or care environments. This is more general care-setting competence than protocol-specific technique.

4 care stages · 0 guidelines · 0 courses · 1 providers

Virtual safety and support management

The program states that the virtual training has been streamlined so students feel safe and supported no matter what arises. This signals competency in maintaining safety in online psychedelic support contexts.

3 care stages · 0 guidelines · 0 courses · 1 providers

General psychedelic-assisted practice skills

Catch-all cluster covering 189 general competencies for psychedelic-assisted clinical practice that did not group into a more specific category — including miscellaneous facilitation, monitoring, ethics, safety, regulatory awareness, group support, and program-specific skills not captured by dedicated clusters elsewhere.

8 care stages · 45 guidelines · 27 courses · 18 providers